"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-112409","R-HSA-112409","RAF-independent MAPK1/3 activation","9/50","23/2914",4.15064384233513e-11,2.11682835959092e-08,1.47238628933362e-08,"MAPK1/CDK1/DUSP16/MAPK3/DUSP10/DUSP7/DUSP2/DUSP8/DUSP9",9
"R-HSA-212436","R-HSA-212436","Generic Transcription Pathway","28/50","481/2914",1.51001046618199e-10,3.85052668876408e-08,2.67828172159648e-08,"AR/MAPK1/SMAD3/SOCS3/SIRT1/CSNK2A1/NR4A1/YAP1/CDK1/CDK2/ZNF521/CHEK1/GSK3B/TP53/CASP1/MEN1/MAPK11/VDR/LAMTOR3/MAPK3/HDAC1/EP300/YWHAZ/PML/SFN/ABL1/NR0B2/RXRB",28
"R-HSA-73857","R-HSA-73857","RNA Polymerase II Transcription","28/50","499/2914",3.72057222163204e-10,6.32497277677447e-08,4.39941346908771e-08,"AR/MAPK1/SMAD3/SOCS3/SIRT1/CSNK2A1/NR4A1/YAP1/CDK1/CDK2/ZNF521/CHEK1/GSK3B/TP53/CASP1/MEN1/MAPK11/VDR/LAMTOR3/MAPK3/HDAC1/EP300/YWHAZ/PML/SFN/ABL1/NR0B2/RXRB",28
"R-HSA-5675221","R-HSA-5675221","Negative regulation of MAPK pathway","8/50","34/2914",5.45023679927817e-08,6.94905191907966e-06,4.83349947725458e-06,"MAPK1/DUSP16/MAPK3/DUSP10/DUSP7/DUSP2/DUSP8/DUSP9",8
"R-HSA-8940973","R-HSA-8940973","RUNX2 regulates osteoblast differentiation","6/50","19/2914",4.30076938714369e-07,4.38678477488656e-05,3.05128270203668e-05,"AR/MAPK1/YAP1/ZNF521/MAPK3/ABL1",6
"R-HSA-8941326","R-HSA-8941326","RUNX2 regulates bone development","6/50","24/2914",1.99867234297051e-06,0.000169887149152494,0.000118167119224748,"AR/MAPK1/YAP1/ZNF521/MAPK3/ABL1",6
"R-HSA-8878166","R-HSA-8878166","Transcriptional regulation by RUNX2","8/50","62/2914",7.05266663196774e-06,0.000513837140329078,0.000357405812777914,"AR/MAPK1/YAP1/CDK1/ZNF521/GSK3B/MAPK3/ABL1",8
"R-HSA-1640170","R-HSA-1640170","Cell Cycle","15/50","249/2914",9.15244602209536e-06,0.000583468433908579,0.000405838724927123,"MAPK1/CSNK2A1/CDK1/CDK2/CHEK1/GSK3B/TP53/CSNK1D/MAPK3/HDAC1/EP300/YWHAZ/SFN/ABL1/FBXW11",15
"R-HSA-3700989","R-HSA-3700989","Transcriptional Regulation by TP53","13/50","194/2914",1.34201700219329e-05,0.000760476301242863,0.00052895874823291,"CSNK2A1/CDK1/CDK2/CHEK1/TP53/CASP1/MAPK11/LAMTOR3/HDAC1/EP300/YWHAZ/PML/SFN",13
"R-HSA-450341","R-HSA-450341","Activation of the AP-1 family of transcription factors","4/50","10/2914",1.49457947253625e-05,0.000762235530993486,0.000530182402362858,"MAPK1/MAPK9/MAPK11/MAPK3",4
"R-HSA-75035","R-HSA-75035","Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex","4/50","11/2914",2.31896920950873e-05,0.00100235794216623,0.00069720253149643,"CDK1/CHEK1/YWHAZ/SFN",4
"R-HSA-5633007","R-HSA-5633007","Regulation of TP53 Activity","9/50","95/2914",2.35848927568525e-05,0.00100235794216623,0.00069720253149643,"CSNK2A1/CDK1/CDK2/CHEK1/TP53/MAPK11/HDAC1/EP300/PML",9
"R-HSA-2262752","R-HSA-2262752","Cellular responses to stress","12/50","187/2914",4.806798286701e-05,0.00179129976539161,0.00124596082752729,"AR/MAPK1/SIRT1/MAPK9/CDK2/GSK3B/TP53/MAPK11/LAMTOR3/MAPK3/EP300/STAT3",12
"R-HSA-6807070","R-HSA-6807070","PTEN Regulation","7/50","59/2914",4.91729347362403e-05,0.00179129976539161,0.00124596082752729,"MAPK1/CSNK2A1/TP53/LAMTOR3/MAPK3/HDAC1/PML",7
"R-HSA-8953897","R-HSA-8953897","Cellular responses to external stimuli","12/50","189/2914",5.34538417243279e-05,0.00181743061862715,0.00126413646744551,"AR/MAPK1/SIRT1/MAPK9/CDK2/GSK3B/TP53/MAPK11/LAMTOR3/MAPK3/EP300/STAT3",12
"R-HSA-69278","R-HSA-69278","Cell Cycle, Mitotic","12/50","191/2914",5.93577330313167e-05,0.00189202774037322,0.00131602342312853,"MAPK1/CSNK2A1/CDK1/CDK2/GSK3B/TP53/CSNK1D/MAPK3/HDAC1/EP300/ABL1/FBXW11",12
"R-HSA-6804758","R-HSA-6804758","Regulation of TP53 Activity through Acetylation","4/50","14/2914",6.77123427879949e-05,0.00203137028363985,0.00141294486189191,"TP53/HDAC1/EP300/PML",4
"R-HSA-2028269","R-HSA-2028269","Signaling by Hippo","4/50","15/2914",9.11703474531179e-05,0.00244720406321527,0.00170218321837677,"YAP1/LATS2/TJP2/LATS1",4
"R-HSA-6804114","R-HSA-6804114","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest","4/50","15/2914",9.11703474531179e-05,0.00244720406321527,0.00170218321837677,"CDK1/TP53/EP300/SFN",4
"R-HSA-1257604","R-HSA-1257604","PIP3 activates AKT signaling","11/50","172/2914",0.000109186513808879,0.00278425610212641,0.00193662395545222,"MAPK1/CSNK2A1/NR4A1/GSK3B/LCK/TP53/LAMTOR3/MAPK3/HDAC1/PML/FGF19",11
"R-HSA-450282","R-HSA-450282","MAPK targets/ Nuclear events mediated by MAP kinases","5/50","30/2914",0.000125146889406161,0.00290113243623374,0.00201791874305628,"MAPK1/MAPK9/MAPK11/MAPK3/DUSP7",5
"R-HSA-6791312","R-HSA-6791312","TP53 Regulates Transcription of Cell Cycle Genes","5/50","30/2914",0.000125146889406161,0.00290113243623374,0.00201791874305628,"CDK1/CDK2/TP53/EP300/SFN",5
"R-HSA-5684996","R-HSA-5684996","MAPK1/MAPK3 signaling","11/50","177/2914",0.000141669875197634,0.00305621051797117,0.00212578523128232,"MAPK1/CDK1/DUSP16/LAMTOR3/MAPK3/DUSP10/DUSP7/FGF19/DUSP2/DUSP8/DUSP9",11
"R-HSA-109606","R-HSA-109606","Intrinsic Pathway for Apoptosis","6/50","49/2914",0.000149814241077018,0.00305621051797117,0.00212578523128232,"MAPK1/TP53/MAPK3/YWHAZ/SFN/STAT3",6
"R-HSA-9614085","R-HSA-9614085","FOXO-mediated transcription","6/50","49/2914",0.000149814241077018,0.00305621051797117,0.00212578523128232,"SMAD3/SIRT1/HDAC1/EP300/YWHAZ/SFN",6
"R-HSA-8943724","R-HSA-8943724","Regulation of PTEN gene transcription","5/50","32/2914",0.000172326768312989,0.00338025583998556,0.0023511789846752,"MAPK1/TP53/LAMTOR3/MAPK3/HDAC1",5
"R-HSA-195258","R-HSA-195258","RHO GTPase Effectors","9/50","130/2914",0.00028035162642507,0.00529553072136243,0.00368337224581865,"AR/MAPK1/MEN1/MAPK11/MAPK3/YWHAZ/SFN/ABL1/CTNNA1",9
"R-HSA-198753","R-HSA-198753","ERK/MAPK targets","4/50","21/2914",0.000370459007321836,0.00674764620479058,0.00469340922809995,"MAPK1/MAPK11/MAPK3/DUSP7",4
"R-HSA-9006925","R-HSA-9006925","Intracellular signaling by second messengers","11/50","201/2914",0.000437829674390052,0.00764343135571786,0.00531648372936412,"MAPK1/CSNK2A1/NR4A1/GSK3B/LCK/TP53/LAMTOR3/MAPK3/HDAC1/PML/FGF19",11
"R-HSA-5683057","R-HSA-5683057","MAPK family signaling cascades","11/50","202/2914",0.000457109096032662,0.00764343135571786,0.00531648372936412,"MAPK1/CDK1/DUSP16/LAMTOR3/MAPK3/DUSP10/DUSP7/FGF19/DUSP2/DUSP8/DUSP9",11
"R-HSA-450294","R-HSA-450294","MAP kinase activation","6/50","60/2914",0.000464600729465203,0.00764343135571786,0.00531648372936412,"MAPK1/MAPK9/MAPK11/MAPK3/DUSP7/FBXW11",6
"R-HSA-5673001","R-HSA-5673001","RAF/MAP kinase cascade","10/50","171/2914",0.00049188612294104,0.00783943508437283,0.00545281656023456,"MAPK1/DUSP16/LAMTOR3/MAPK3/DUSP10/DUSP7/FGF19/DUSP2/DUSP8/DUSP9",10
"R-HSA-8878171","R-HSA-8878171","Transcriptional regulation by RUNX1","7/50","86/2914",0.000543887693956876,0.00833687823726743,0.00579881933118498,"SOCS3/CSNK2A1/YAP1/HDAC1/EP300/PML/ABL1",7
"R-HSA-69481","R-HSA-69481","G2/M Checkpoints","6/50","62/2914",0.000555791882484495,0.00833687823726743,0.00579881933118498,"CDK1/CDK2/CHEK1/TP53/YWHAZ/SFN",6
"R-HSA-198725","R-HSA-198725","Nuclear Events (kinase and transcription factor activation)","4/50","24/2914",0.000633205050761072,0.00897040488578186,0.00623947666978016,"MAPK1/MAPK11/MAPK3/DUSP7",4
"R-HSA-982772","R-HSA-982772","Growth hormone receptor signaling","4/50","24/2914",0.000633205050761072,0.00897040488578186,0.00623947666978016,"MAPK1/SOCS3/MAPK3/STAT3",4
"R-HSA-448424","R-HSA-448424","Interleukin-17 signaling","6/50","64/2914",0.000660377205933797,0.00910249662233071,0.00633135471976357,"MAPK1/MAPK9/MAPK11/MAPK3/DUSP7/FBXW11",6
"R-HSA-69275","R-HSA-69275","G2/M Transition","6/50","66/2914",0.000779666824744324,0.0104061583860293,0.00723813287119066,"CDK1/CDK2/TP53/CSNK1D/EP300/FBXW11",6
"R-HSA-2559580","R-HSA-2559580","Oxidative Stress Induced Senescence","5/50","44/2914",0.000795765053049299,0.0104061583860293,0.00723813287119066,"MAPK1/MAPK9/TP53/MAPK11/MAPK3",5
"R-HSA-453274","R-HSA-453274","Mitotic G2-G2/M phases","6/50","68/2914",0.000915029298533863,0.0113450651791786,0.00789120116694159,"CDK1/CDK2/TP53/CSNK1D/EP300/FBXW11",6
"R-HSA-202670","R-HSA-202670","ERKs are inactivated","3/50","12/2914",0.000938197929145176,0.0113450651791786,0.00789120116694159,"MAPK1/MAPK3/DUSP7",3
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","14/50","332/2914",0.000952418025273401,0.0113450651791786,0.00789120116694159,"MAPK1/SMAD3/SOCS3/MAPK9/LCK/TP53/CASP1/MAPK11/MAPK3/YWHAZ/DUSP7/SYK/STAT3/FBXW11",14
"R-HSA-383280","R-HSA-383280","Nuclear Receptor transcription pathway","5/50","46/2914",0.000978789937027177,0.0113450651791786,0.00789120116694159,"AR/NR4A1/VDR/NR0B2/RXRB",5
"R-HSA-69473","R-HSA-69473","G2/M DNA damage checkpoint","5/50","46/2914",0.000978789937027177,0.0113450651791786,0.00789120116694159,"CDK1/CHEK1/TP53/YWHAZ/SFN",5
"R-HSA-9616222","R-HSA-9616222","Transcriptional regulation of granulopoiesis","4/50","27/2914",0.00100684981688819,0.0114109645913995,0.00793703832260395,"CDK2/EP300/PML/STAT3",4
"R-HSA-9607240","R-HSA-9607240","FLT3 Signaling","10/50","188/2914",0.00104273569342665,0.0115607652966867,0.00804123406601327,"MAPK1/DUSP16/LAMTOR3/MAPK3/DUSP10/DUSP7/FGF19/DUSP2/DUSP8/DUSP9",10
"R-HSA-2559583","R-HSA-2559583","Cellular Senescence","7/50","99/2914",0.00127089855328859,0.0137906013229187,0.00959222424318597,"MAPK1/MAPK9/CDK2/TP53/MAPK11/MAPK3/STAT3",7
"R-HSA-3371556","R-HSA-3371556","Cellular response to heat stress","5/50","49/2914",0.00130986750947965,0.0139173422882213,0.00968038049768953,"MAPK1/SIRT1/GSK3B/MAPK3/EP300",5
"R-HSA-109581","R-HSA-109581","Apoptosis","7/50","101/2914",0.00143033687543443,0.0148871797239094,0.0103549629864963,"MAPK1/TP53/MAPK3/YWHAZ/SFN/STAT3/TJP2",7
"R-HSA-2871796","R-HSA-2871796","FCERI mediated MAPK activation","4/50","30/2914",0.00151371875329243,0.0154399312835828,0.0107394362075695,"MAPK1/MAPK9/MAPK3/SYK",4
"R-HSA-5357801","R-HSA-5357801","Programmed Cell Death","7/50","103/2914",0.00160508190019587,0.0160508190019587,0.0111643467567803,"MAPK1/TP53/MAPK3/YWHAZ/SFN/STAT3/TJP2",7
"R-HSA-5250913","R-HSA-5250913","Positive epigenetic regulation of rRNA expression","3/50","15/2914",0.00187110883972959,0.0171633915810869,0.0119382104495899,"GSK3B/HDAC1/EP300",3
"R-HSA-9008059","R-HSA-9008059","Interleukin-37 signaling","3/50","15/2914",0.00187110883972959,0.0171633915810869,0.0119382104495899,"SMAD3/CASP1/STAT3",3
"R-HSA-168142","R-HSA-168142","Toll Like Receptor 10 (TLR10) Cascade","6/50","78/2914",0.00188460770302131,0.0171633915810869,0.0119382104495899,"MAPK1/MAPK9/MAPK11/MAPK3/DUSP7/FBXW11",6
"R-HSA-168176","R-HSA-168176","Toll Like Receptor 5 (TLR5) Cascade","6/50","78/2914",0.00188460770302131,0.0171633915810869,0.0119382104495899,"MAPK1/MAPK9/MAPK11/MAPK3/DUSP7/FBXW11",6
"R-HSA-975871","R-HSA-975871","MyD88 cascade initiated on plasma membrane","6/50","78/2914",0.00188460770302131,0.0171633915810869,0.0119382104495899,"MAPK1/MAPK9/MAPK11/MAPK3/DUSP7/FBXW11",6
"R-HSA-3371453","R-HSA-3371453","Regulation of HSF1-mediated heat shock response","4/50","32/2914",0.001936698399208,0.0173283540981769,0.0120529521797432,"MAPK1/SIRT1/GSK3B/MAPK3",4
"R-HSA-201681","R-HSA-201681","TCF dependent signaling in response to WNT","7/50","108/2914",0.00211552122059006,0.0186019969396712,0.0129388502965309,"CSNK2A1/GSK3B/MEN1/AMER1/HDAC1/EP300/YWHAZ",7
"R-HSA-5668599","R-HSA-5668599","RHO GTPases Activate NADPH Oxidases","3/50","16/2914",0.00227520451568994,0.0196670220847774,0.0136796417803302,"MAPK1/MAPK11/MAPK3",3
"R-HSA-6804756","R-HSA-6804756","Regulation of TP53 Activity through Phosphorylation","5/50","56/2914",0.00239724113894284,0.0203765496810142,0.0141731625232235,"CSNK2A1/CDK2/CHEK1/TP53/MAPK11",5
"R-HSA-975138","R-HSA-975138","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","6/50","83/2914",0.00259460593685966,0.021692607013089,0.0150885625663797,"MAPK1/MAPK9/MAPK11/MAPK3/DUSP7/FBXW11",6
"R-HSA-5628897","R-HSA-5628897","TP53 Regulates Metabolic Genes","4/50","35/2914",0.00271515836834546,0.0219777148763834,0.0152868728861531,"TP53/LAMTOR3/YWHAZ/SFN",4
"R-HSA-168181","R-HSA-168181","Toll Like Receptor 7/8 (TLR7/8) Cascade","6/50","84/2914",0.0027579877491932,0.0219777148763834,0.0152868728861531,"MAPK1/MAPK9/MAPK11/MAPK3/DUSP7/FBXW11",6
"R-HSA-975155","R-HSA-975155","MyD88 dependent cascade initiated on endosome","6/50","84/2914",0.0027579877491932,0.0219777148763834,0.0152868728861531,"MAPK1/MAPK9/MAPK11/MAPK3/DUSP7/FBXW11",6
"R-HSA-166058","R-HSA-166058","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","6/50","86/2914",0.00310789331051382,0.023657098333762,0.0164549889339067,"MAPK1/MAPK9/MAPK11/MAPK3/DUSP7/FBXW11",6
"R-HSA-168138","R-HSA-168138","Toll Like Receptor 9 (TLR9) Cascade","6/50","86/2914",0.00310789331051382,0.023657098333762,0.0164549889339067,"MAPK1/MAPK9/MAPK11/MAPK3/DUSP7/FBXW11",6
"R-HSA-168188","R-HSA-168188","Toll Like Receptor TLR6:TLR2 Cascade","6/50","86/2914",0.00310789331051382,0.023657098333762,0.0164549889339067,"MAPK1/MAPK9/MAPK11/MAPK3/DUSP7/FBXW11",6
"R-HSA-168164","R-HSA-168164","Toll Like Receptor 3 (TLR3) Cascade","6/50","87/2914",0.00329486464574602,0.0239878585292387,0.0166850533010391,"MAPK1/MAPK9/MAPK11/MAPK3/DUSP7/FBXW11",6
"R-HSA-168179","R-HSA-168179","Toll Like Receptor TLR1:TLR2 Cascade","6/50","87/2914",0.00329486464574602,0.0239878585292387,0.0166850533010391,"MAPK1/MAPK9/MAPK11/MAPK3/DUSP7/FBXW11",6
"R-HSA-181438","R-HSA-181438","Toll Like Receptor 2 (TLR2) Cascade","6/50","87/2914",0.00329486464574602,0.0239878585292387,0.0166850533010391,"MAPK1/MAPK9/MAPK11/MAPK3/DUSP7/FBXW11",6
"R-HSA-212165","R-HSA-212165","Epigenetic regulation of gene expression","4/50","37/2914",0.00333948618740382,0.0239878585292387,0.0166850533010391,"SIRT1/GSK3B/HDAC1/EP300",4
"R-HSA-1538133","R-HSA-1538133","G0 and Early G1","3/50","19/2914",0.00379672489025628,0.0268934679726487,0.0187060860821106,"CDK1/CDK2/HDAC1",3
"R-HSA-166166","R-HSA-166166","MyD88-independent TLR4 cascade ","6/50","90/2914",0.00390656795297118,0.0269236440002068,0.0187270753933327,"MAPK1/MAPK9/MAPK11/MAPK3/DUSP7/FBXW11",6
"R-HSA-937061","R-HSA-937061","TRIF(TICAM1)-mediated TLR4 signaling ","6/50","90/2914",0.00390656795297118,0.0269236440002068,0.0187270753933327,"MAPK1/MAPK9/MAPK11/MAPK3/DUSP7/FBXW11",6
"R-HSA-445144","R-HSA-445144","Signal transduction by L1","3/50","20/2914",0.00441313751397954,0.0300093350950609,0.0208733662064716,"MAPK1/CSNK2A1/MAPK3",3
"R-HSA-5663202","R-HSA-5663202","Diseases of signal transduction","11/50","268/2914",0.00466271618198839,0.0312892796422905,0.0217636475530483,"MAPK1/SMAD3/NR4A1/GSK3B/LCK/AMER1/MAPK3/HDAC1/EP300/FGF19/STAT3",11
"R-HSA-2029482","R-HSA-2029482","Regulation of actin dynamics for phagocytic cup formation","4/50","43/2914",0.00578582752591553,0.0375690703205897,0.0261316340516795,"MAPK1/MAPK3/SYK/ABL1",4
"R-HSA-201722","R-HSA-201722","Formation of the beta-catenin:TCF transactivating complex","3/50","22/2914",0.00581952265750311,0.0375690703205897,0.0261316340516795,"MEN1/HDAC1/EP300",3
"R-HSA-525793","R-HSA-525793","Myogenesis","3/50","22/2914",0.00581952265750311,0.0375690703205897,0.0261316340516795,"MAPK11/ABL1/CTNNA1",3
"R-HSA-187037","R-HSA-187037","Signaling by NTRK1 (TRKA)","5/50","70/2914",0.00634201991740169,0.0404303769734358,0.028121851475847,"MAPK1/MAPK11/MAPK3/DUSP7/STAT3",5
"R-HSA-2559585","R-HSA-2559585","Oncogene Induced Senescence","3/50","23/2914",0.00661229187450153,0.0416329488394541,0.0289583152918391,"MAPK1/TP53/MAPK3",3
"R-HSA-2559582","R-HSA-2559582","Senescence-Associated Secretory Phenotype (SASP)","4/50","45/2914",0.00681176944298074,0.0423658831209778,0.0294681168457575,"MAPK1/CDK2/MAPK3/STAT3",4
"R-HSA-2173796","R-HSA-2173796","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription","3/50","24/2914",0.00746644713503588,0.0447986828102153,0.0311602809226885,"SMAD3/MEN1/HDAC1",3
"R-HSA-5625740","R-HSA-5625740","RHO GTPases activate PKNs","3/50","24/2914",0.00746644713503588,0.0447986828102153,0.0311602809226885,"AR/YWHAZ/SFN",3
"R-HSA-69615","R-HSA-69615","G1/S DNA Damage Checkpoints","3/50","24/2914",0.00746644713503588,0.0447986828102153,0.0311602809226885,"CDK2/CHEK1/TP53",3
"R-HSA-5663213","R-HSA-5663213","RHO GTPases Activate WASPs and WAVEs","3/50","25/2914",0.00838309893964078,0.0497137262699628,0.0345790005221413,"MAPK1/MAPK3/ABL1",3
"R-HSA-3108232","R-HSA-3108232","SUMO E3 ligases SUMOylate target proteins","6/50","107/2914",0.00908672293816263,0.0532669965340568,0.0370505218410261,"AR/TP53/VDR/HDAC1/EP300/PML",6
"R-HSA-2990846","R-HSA-2990846","SUMOylation","6/50","109/2914",0.00992002832674508,0.0574910732572727,0.0399886309343672,"AR/TP53/VDR/HDAC1/EP300/PML",6
"R-HSA-166016","R-HSA-166016","Toll Like Receptor 4 (TLR4) Cascade","6/50","110/2914",0.0103566526909425,0.0593471109256258,0.0412796210153476,"MAPK1/MAPK9/MAPK11/MAPK3/DUSP7/FBXW11",6
"R-HSA-5654733","R-HSA-5654733","Negative regulation of FGFR4 signaling","3/50","28/2914",0.0115175487420068,0.0625331388539658,0.0434957023607564,"MAPK1/MAPK3/FGF19",3
"R-HSA-110056","R-HSA-110056","MAPK3 (ERK1) activation","2/50","10/2914",0.0118935577820288,0.0625331388539658,0.0434957023607564,"CDK1/MAPK3",2
"R-HSA-111458","R-HSA-111458","Formation of apoptosome","2/50","10/2914",0.0118935577820288,0.0625331388539658,0.0434957023607564,"MAPK1/MAPK3",2
"R-HSA-1362300","R-HSA-1362300","Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1","2/50","10/2914",0.0118935577820288,0.0625331388539658,0.0434957023607564,"CDK1/HDAC1",2
"R-HSA-5250924","R-HSA-5250924","B-WICH complex positively regulates rRNA expression","2/50","10/2914",0.0118935577820288,0.0625331388539658,0.0434957023607564,"GSK3B/EP300",2
"R-HSA-74749","R-HSA-74749","Signal attenuation","2/50","10/2914",0.0118935577820288,0.0625331388539658,0.0434957023607564,"MAPK1/MAPK3",2
"R-HSA-9617629","R-HSA-9617629","Regulation of FOXO transcriptional activity by acetylation","2/50","10/2914",0.0118935577820288,0.0625331388539658,0.0434957023607564,"SIRT1/EP300",2
"R-HSA-9627069","R-HSA-9627069","Regulation of the apoptosome activity","2/50","10/2914",0.0118935577820288,0.0625331388539658,0.0434957023607564,"MAPK1/MAPK3",2
"R-HSA-8878159","R-HSA-8878159","Transcriptional regulation by RUNX3","4/50","53/2914",0.0121077889757257,0.0628498225772873,0.0437159756626333,"SMAD3/YAP1/TP53/EP300",4
"R-HSA-69620","R-HSA-69620","Cell Cycle Checkpoints","6/50","114/2914",0.0122415087213993,0.0628498225772873,0.0437159756626333,"CDK1/CDK2/CHEK1/TP53/YWHAZ/SFN",6
"R-HSA-597592","R-HSA-597592","Post-translational protein modification","13/50","393/2914",0.0126476156094716,0.0628498225772873,0.0437159756626333,"AR/SMAD3/SOCS3/CDK1/FBXO22/TP53/MEN1/VDR/CSNK1D/HDAC1/EP300/PML/FBXW11",13
"R-HSA-114452","R-HSA-114452","Activation of BH3-only proteins","3/50","29/2914",0.0126931994616874,0.0628498225772873,0.0437159756626333,"TP53/YWHAZ/SFN",3
"R-HSA-6804757","R-HSA-6804757","Regulation of TP53 Degradation","3/50","29/2914",0.0126931994616874,0.0628498225772873,0.0437159756626333,"CDK1/CDK2/TP53",3
"R-HSA-6806003","R-HSA-6806003","Regulation of TP53 Expression and Degradation","3/50","29/2914",0.0126931994616874,0.0628498225772873,0.0437159756626333,"CDK1/CDK2/TP53",3
"R-HSA-1266738","R-HSA-1266738","Developmental Biology","13/50","397/2914",0.0137223001353659,0.0660624420976744,0.0459505531205702,"MAPK1/SMAD3/CSNK2A1/CDK2/KDM6A/GSK3B/MAPK11/MAPK3/EP300/PML/ABL1/STAT3/CTNNA1",13
"R-HSA-194315","R-HSA-194315","Signaling by Rho GTPases","9/50","228/2914",0.013779241562074,0.0660624420976744,0.0459505531205702,"AR/MAPK1/MEN1/MAPK11/MAPK3/YWHAZ/SFN/ABL1/CTNNA1",9
"R-HSA-390466","R-HSA-390466","Chaperonin-mediated protein folding","3/50","30/2914",0.0139353639848425,0.0660624420976744,0.0459505531205702,"CSNK2A1/TP53/STAT3",3
"R-HSA-1059683","R-HSA-1059683","Interleukin-6 signaling","2/50","11/2914",0.0143782962212585,0.0660624420976744,0.0459505531205702,"SOCS3/STAT3",2
"R-HSA-2586552","R-HSA-2586552","Signaling by Leptin","2/50","11/2914",0.0143782962212585,0.0660624420976744,0.0459505531205702,"SOCS3/STAT3",2
"R-HSA-6803207","R-HSA-6803207","TP53 Regulates Transcription of Caspase Activators and Caspases","2/50","11/2914",0.0143782962212585,0.0660624420976744,0.0459505531205702,"TP53/CASP1",2
"R-HSA-6804116","R-HSA-6804116","TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest","2/50","11/2914",0.0143782962212585,0.0660624420976744,0.0459505531205702,"CDK2/TP53",2
"R-HSA-9614399","R-HSA-9614399","Regulation of localization of FOXO transcription factors","2/50","11/2914",0.0143782962212585,0.0660624420976744,0.0459505531205702,"YWHAZ/SFN",2
"R-HSA-3769402","R-HSA-3769402","Deactivation of the beta-catenin transactivating complex","3/50","31/2914",0.0152445652747885,0.0688029052224967,0.047856716326071,"MEN1/HDAC1/YWHAZ",3
"R-HSA-391251","R-HSA-391251","Protein folding","3/50","31/2914",0.0152445652747885,0.0688029052224967,0.047856716326071,"CSNK2A1/TP53/STAT3",3
"R-HSA-2454202","R-HSA-2454202","Fc epsilon receptor (FCERI) signaling","5/50","87/2914",0.0155630724120748,0.0696242713171768,0.0484280277273242,"MAPK1/MAPK9/MAPK3/SYK/FBXW11",5
"R-HSA-166520","R-HSA-166520","Signaling by NTRKs","5/50","89/2914",0.0170401416358362,0.0737611957511646,0.0513055169621104,"MAPK1/MAPK11/MAPK3/DUSP7/STAT3",5
"R-HSA-111461","R-HSA-111461","Cytochrome c-mediated apoptotic response","2/50","12/2914",0.0170663158796812,0.0737611957511646,0.0513055169621104,"MAPK1/MAPK3",2
"R-HSA-170968","R-HSA-170968","Frs2-mediated activation","2/50","12/2914",0.0170663158796812,0.0737611957511646,0.0513055169621104,"MAPK1/MAPK3",2
"R-HSA-9020558","R-HSA-9020558","Interleukin-2 signaling","2/50","12/2914",0.0170663158796812,0.0737611957511646,0.0513055169621104,"LCK/SYK",2
"R-HSA-187687","R-HSA-187687","Signalling to ERKs","3/50","33/2914",0.0180657477067865,0.0767794277538428,0.0534048857647988,"MAPK1/MAPK11/MAPK3",3
"R-HSA-68875","R-HSA-68875","Mitotic Prophase","3/50","33/2914",0.0180657477067865,0.0767794277538428,0.0534048857647988,"MAPK1/CDK1/MAPK3",3
"R-HSA-5674135","R-HSA-5674135","MAP2K and MAPK activation","3/50","34/2914",0.0195783625180834,0.0780109702478954,0.0542615004613844,"MAPK1/LAMTOR3/MAPK3",3
"R-HSA-169893","R-HSA-169893","Prolonged ERK activation events","2/50","13/2914",0.0199501983827092,0.0780109702478954,0.0542615004613844,"MAPK1/MAPK3",2
"R-HSA-4839735","R-HSA-4839735","AXIN mutants destabilize the destruction complex, activating WNT signaling","2/50","13/2914",0.0199501983827092,0.0780109702478954,0.0542615004613844,"GSK3B/AMER1",2
"R-HSA-4839744","R-HSA-4839744","truncated APC mutants destabilize the destruction complex","2/50","13/2914",0.0199501983827092,0.0780109702478954,0.0542615004613844,"GSK3B/AMER1",2
"R-HSA-4839748","R-HSA-4839748","AMER1 mutants destabilize the destruction complex","2/50","13/2914",0.0199501983827092,0.0780109702478954,0.0542615004613844,"GSK3B/AMER1",2
"R-HSA-5467337","R-HSA-5467337","APC truncation mutants have impaired AXIN binding","2/50","13/2914",0.0199501983827092,0.0780109702478954,0.0542615004613844,"GSK3B/AMER1",2
"R-HSA-5467340","R-HSA-5467340","AXIN missense mutants destabilize the destruction complex","2/50","13/2914",0.0199501983827092,0.0780109702478954,0.0542615004613844,"GSK3B/AMER1",2
"R-HSA-5467348","R-HSA-5467348","Truncations of AMER1 destabilize the destruction complex","2/50","13/2914",0.0199501983827092,0.0780109702478954,0.0542615004613844,"GSK3B/AMER1",2
"R-HSA-5626467","R-HSA-5626467","RHO GTPases activate IQGAPs","2/50","13/2914",0.0199501983827092,0.0780109702478954,0.0542615004613844,"MEN1/CTNNA1",2
"R-HSA-6804760","R-HSA-6804760","Regulation of TP53 Activity through Methylation","2/50","13/2914",0.0199501983827092,0.0780109702478954,0.0542615004613844,"TP53/EP300",2
"R-HSA-168898","R-HSA-168898","Toll-like Receptor Cascades","6/50","127/2914",0.0200381119656359,0.0780109702478954,0.0542615004613844,"MAPK1/MAPK9/MAPK11/MAPK3/DUSP7/FBXW11",6
"R-HSA-2029480","R-HSA-2029480","Fcgamma receptor (FCGR) dependent phagocytosis","4/50","62/2914",0.0206080313292548,0.0790232780294734,0.0549656237274149,"MAPK1/MAPK3/SYK/ABL1",4
"R-HSA-983231","R-HSA-983231","Factors involved in megakaryocyte development and platelet production","4/50","62/2914",0.0206080313292548,0.0790232780294734,0.0549656237274149,"CDK2/TP53/HDAC1/ABL1",4
"R-HSA-2173793","R-HSA-2173793","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","3/50","36/2914",0.0228086540018453,0.0832736364588913,0.057922013388331,"SMAD3/MEN1/HDAC1",3
"R-HSA-1295596","R-HSA-1295596","Spry regulation of FGF signaling","2/50","14/2914",0.0230227112562817,0.0832736364588913,0.057922013388331,"MAPK1/MAPK3",2
"R-HSA-4839743","R-HSA-4839743","phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex","2/50","14/2914",0.0230227112562817,0.0832736364588913,0.057922013388331,"GSK3B/AMER1",2
"R-HSA-5339716","R-HSA-5339716","Misspliced GSK3beta mutants stabilize beta-catenin","2/50","14/2914",0.0230227112562817,0.0832736364588913,0.057922013388331,"GSK3B/AMER1",2
"R-HSA-5358747","R-HSA-5358747","S33 mutants of beta-catenin aren't phosphorylated","2/50","14/2914",0.0230227112562817,0.0832736364588913,0.057922013388331,"GSK3B/AMER1",2
"R-HSA-5358749","R-HSA-5358749","S37 mutants of beta-catenin aren't phosphorylated","2/50","14/2914",0.0230227112562817,0.0832736364588913,0.057922013388331,"GSK3B/AMER1",2
"R-HSA-5358751","R-HSA-5358751","S45 mutants of beta-catenin aren't phosphorylated","2/50","14/2914",0.0230227112562817,0.0832736364588913,0.057922013388331,"GSK3B/AMER1",2
"R-HSA-5358752","R-HSA-5358752","T41 mutants of beta-catenin aren't phosphorylated","2/50","14/2914",0.0230227112562817,0.0832736364588913,0.057922013388331,"GSK3B/AMER1",2
"R-HSA-195253","R-HSA-195253","Degradation of beta-catenin by the destruction complex","3/50","37/2914",0.0245265217501784,0.0873766422804207,0.0607759101104268,"GSK3B/AMER1/HDAC1",3
"R-HSA-2565942","R-HSA-2565942","Regulation of PLK1 Activity at G2/M Transition","3/50","37/2914",0.0245265217501784,0.0873766422804207,0.0607759101104268,"CDK1/CSNK1D/FBXW11",3
"R-HSA-168249","R-HSA-168249","Innate Immune System","13/50","428/2914",0.0246710519380011,0.0873766422804207,0.0607759101104268,"MAPK1/MAPK9/LCK/CASP1/MAPK11/LAMTOR3/MAPK3/EP300/DUSP7/SYK/ABL1/PTPRB/FBXW11",13
"R-HSA-195721","R-HSA-195721","Signaling by WNT","7/50","172/2914",0.0256067068516045,0.0900649689263332,0.0626458091396786,"CSNK2A1/GSK3B/MEN1/AMER1/HDAC1/EP300/YWHAZ",7
"R-HSA-111447","R-HSA-111447","Activation of BAD and translocation to mitochondria ","2/50","15/2914",0.0262768039357512,0.0906727822831795,0.0630685812784964,"YWHAZ/SFN",2
"R-HSA-69205","R-HSA-69205","G1/S-Specific Transcription","2/50","15/2914",0.0262768039357512,0.0906727822831795,0.0630685812784964,"CDK1/HDAC1",2
"R-HSA-5654743","R-HSA-5654743","Signaling by FGFR4","3/50","38/2914",0.0263128858390403,0.0906727822831795,0.0630685812784964,"MAPK1/MAPK3/FGF19",3
"R-HSA-111471","R-HSA-111471","Apoptotic factor-mediated response","2/50","16/2914",0.0297056038529029,0.0996701181906611,0.0693267901553205,"MAPK1/MAPK3",2
"R-HSA-176187","R-HSA-176187","Activation of ATR in response to replication stress","2/50","16/2914",0.0297056038529029,0.0996701181906611,0.0693267901553205,"CDK2/CHEK1",2
"R-HSA-196299","R-HSA-196299","Beta-catenin phosphorylation cascade","2/50","16/2914",0.0297056038529029,0.0996701181906611,0.0693267901553205,"GSK3B/AMER1",2
"R-HSA-8852276","R-HSA-8852276","The role of GTSE1 in G2/M progression after G2 checkpoint","2/50","16/2914",0.0297056038529029,0.0996701181906611,0.0693267901553205,"CDK1/TP53",2
"R-HSA-9013694","R-HSA-9013694","Signaling by NOTCH4","3/50","40/2914",0.0300907673978156,0.100302557992719,0.0697666915243471,"SMAD3/EP300/YWHAZ",3
"R-HSA-157118","R-HSA-157118","Signaling by NOTCH","5/50","104/2914",0.0311591081901385,0.103189254395913,0.0717745691051037,"SMAD3/TP53/HDAC1/EP300/YWHAZ",5
"R-HSA-1433557","R-HSA-1433557","Signaling by SCF-KIT","3/50","41/2914",0.0320819680214517,0.104883356993208,0.0729529232336656,"CHEK1/LCK/STAT3",3
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","3/50","41/2914",0.0320819680214517,0.104883356993208,0.0729529232336656,"LCK/SYK/STAT3",3
"R-HSA-68886","R-HSA-68886","M Phase","5/50","105/2914",0.0323018053658379,0.104929431443168,0.0729849708902943,"MAPK1/CSNK2A1/CDK1/CSNK1D/MAPK3",5
"R-HSA-5250941","R-HSA-5250941","Negative epigenetic regulation of rRNA expression","2/50","17/2914",0.0333024125996734,0.106819059281971,0.0742993250320419,"SIRT1/HDAC1",2
"R-HSA-9013695","R-HSA-9013695","NOTCH4 Intracellular Domain Regulates Transcription","2/50","17/2914",0.0333024125996734,0.106819059281971,0.0742993250320419,"SMAD3/EP300",2
"R-HSA-69273","R-HSA-69273","Cyclin A/B1/B2 associated events during G2/M transition","2/50","18/2914",0.0370607021671642,0.116672580896628,0.0811530645245897,"CDK1/CDK2",2
"R-HSA-881907","R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","2/50","18/2914",0.0370607021671642,0.116672580896628,0.0811530645245897,"MAPK1/MAPK3",2
"R-HSA-8939243","R-HSA-8939243","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known","2/50","18/2914",0.0370607021671642,0.116672580896628,0.0811530645245897,"CSNK2A1/EP300",2
"R-HSA-9029569","R-HSA-9029569","NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux","2/50","19/2914",0.0409741112585652,0.127419492328465,0.0886282124142263,"EP300/RXRB",2
"R-HSA-9615017","R-HSA-9615017","FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes","2/50","19/2914",0.0409741112585652,0.127419492328465,0.0886282124142263,"SMAD3/HDAC1",2
"R-HSA-453279","R-HSA-453279","Mitotic G1-G1/S phases","4/50","77/2914",0.0414701885835905,0.128180582894734,0.0891575984221371,"CDK1/CDK2/HDAC1/ABL1",4
"R-HSA-2173795","R-HSA-2173795","Downregulation of SMAD2/3:SMAD4 transcriptional activity","2/50","20/2914",0.0450364416746302,0.13474178890568,0.0937213268549315,"SMAD3/HDAC1",2
"R-HSA-73854","R-HSA-73854","RNA Polymerase I Promoter Clearance","2/50","20/2914",0.0450364416746302,0.13474178890568,0.0937213268549315,"MAPK3/HDAC1",2
"R-HSA-73864","R-HSA-73864","RNA Polymerase I Transcription","2/50","20/2914",0.0450364416746302,0.13474178890568,0.0937213268549315,"MAPK3/HDAC1",2
"R-HSA-8936459","R-HSA-8936459","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","2/50","20/2914",0.0450364416746302,0.13474178890568,0.0937213268549315,"HDAC1/EP300",2
"R-HSA-877300","R-HSA-877300","Interferon gamma signaling","3/50","47/2914",0.0454423288074059,0.13474178890568,0.0937213268549315,"SOCS3/CIITA/PML",3
"R-HSA-8848021","R-HSA-8848021","Signaling by PTK6","3/50","47/2914",0.0454423288074059,0.13474178890568,0.0937213268549315,"SOCS3/CDK2/STAT3",3
"R-HSA-9006927","R-HSA-9006927","Signaling by Non-Receptor Tyrosine Kinases","3/50","47/2914",0.0454423288074059,0.13474178890568,0.0937213268549315,"SOCS3/CDK2/STAT3",3
"R-HSA-5693532","R-HSA-5693532","DNA Double-Strand Break Repair","4/50","81/2914",0.048514895847525,0.143020791226808,0.0994798898729292,"CDK2/CHEK1/TP53/ABL1",4
"R-HSA-446652","R-HSA-446652","Interleukin-1 family signaling","4/50","82/2914",0.0503744316012127,0.14764919607252,0.102699234419895,"SMAD3/CASP1/STAT3/FBXW11",4
"R-HSA-442742","R-HSA-442742","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","2/50","22/2914",0.0535838679816582,0.153526812756436,0.106787483795499,"MAPK1/MAPK3",2
"R-HSA-69563","R-HSA-69563","p53-Dependent G1 DNA Damage Response","2/50","22/2914",0.0535838679816582,0.153526812756436,0.106787483795499,"CDK2/TP53",2
"R-HSA-69580","R-HSA-69580","p53-Dependent G1/S DNA damage checkpoint","2/50","22/2914",0.0535838679816582,0.153526812756436,0.106787483795499,"CDK2/TP53",2
"R-HSA-9024446","R-HSA-9024446","NR1H2 and NR1H3-mediated signaling","2/50","22/2914",0.0535838679816582,0.153526812756436,0.106787483795499,"EP300/RXRB",2
"R-HSA-8951664","R-HSA-8951664","Neddylation","3/50","51/2914",0.0556623116074367,0.158590943685993,0.110309903038554,"SOCS3/FBXO22/FBXW11",3
"R-HSA-1912408","R-HSA-1912408","Pre-NOTCH Transcription and Translation","2/50","23/2914",0.058057351420435,0.161803629892583,0.112544526880909,"TP53/EP300",2
"R-HSA-6783589","R-HSA-6783589","Interleukin-6 family signaling","2/50","23/2914",0.058057351420435,0.161803629892583,0.112544526880909,"SOCS3/STAT3",2
"R-HSA-400253","R-HSA-400253","Circadian Clock","3/50","52/2914",0.0583762115690887,0.161803629892583,0.112544526880909,"SIRT1/CSNK1D/EP300",3
"R-HSA-74751","R-HSA-74751","Insulin receptor signalling cascade","3/50","52/2914",0.0583762115690887,0.161803629892583,0.112544526880909,"MAPK1/MAPK3/FGF19",3
"R-HSA-74752","R-HSA-74752","Signaling by Insulin receptor","3/50","52/2914",0.0583762115690887,0.161803629892583,0.112544526880909,"MAPK1/MAPK3/FGF19",3
"R-HSA-5688426","R-HSA-5688426","Deubiquitination","5/50","124/2914",0.0591249275829476,0.162993043607045,0.113371838380958,"AR/SMAD3/CDK1/TP53/EP300",5
"R-HSA-373760","R-HSA-373760","L1CAM interactions","3/50","53/2914",0.0611523169246904,0.167302761853496,0.11636951650078,"MAPK1/CSNK2A1/MAPK3",3
"R-HSA-2172127","R-HSA-2172127","DAP12 interactions","2/50","24/2914",0.0626565245372895,0.167302761853496,0.11636951650078,"LCK/SYK",2
"R-HSA-2424491","R-HSA-2424491","DAP12 signaling","2/50","24/2914",0.0626565245372895,0.167302761853496,0.11636951650078,"LCK/SYK",2
"R-HSA-2559586","R-HSA-2559586","DNA Damage/Telomere Stress Induced Senescence","2/50","24/2914",0.0626565245372895,0.167302761853496,0.11636951650078,"CDK2/TP53",2
"R-HSA-5674400","R-HSA-5674400","Constitutive Signaling by AKT1 E17K in Cancer","2/50","24/2914",0.0626565245372895,0.167302761853496,0.11636951650078,"NR4A1/GSK3B",2
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","2/50","24/2914",0.0626565245372895,0.167302761853496,0.11636951650078,"MAPK1/MAPK3",2
"R-HSA-109582","R-HSA-109582","Hemostasis","9/50","298/2914",0.0632578589736862,0.168028687898854,0.116874443388883,"MAPK1/CDK2/LCK/TP53/MAPK3/HDAC1/YWHAZ/SYK/ABL1",9
"R-HSA-9006934","R-HSA-9006934","Signaling by Receptor Tyrosine Kinases","10/50","347/2914",0.0661734874018858,0.174425055601856,0.12132351648674,"MAPK1/YAP1/CHEK1/LCK/MAPK11/MAPK3/DUSP7/FGF19/STAT3/CTNNA1",10
"R-HSA-190236","R-HSA-190236","Signaling by FGFR","3/50","55/2914",0.0668881863436833,0.174425055601856,0.12132351648674,"MAPK1/MAPK3/FGF19",3
"R-HSA-380259","R-HSA-380259","Loss of Nlp from mitotic centrosomes","2/50","25/2914",0.0673759528501285,0.174425055601856,0.12132351648674,"CDK1/CSNK1D",2
"R-HSA-380284","R-HSA-380284","Loss of proteins required for interphase microtubule organization from the centrosome","2/50","25/2914",0.0673759528501285,0.174425055601856,0.12132351648674,"CDK1/CSNK1D",2
"R-HSA-456926","R-HSA-456926","Thrombin signalling through proteinase activated receptors (PARs)","2/50","25/2914",0.0673759528501285,0.174425055601856,0.12132351648674,"MAPK1/MAPK3",2
"R-HSA-68877","R-HSA-68877","Mitotic Prometaphase","3/50","56/2914",0.0698464029373824,0.179907401505379,0.12513683035565,"CSNK2A1/CDK1/CSNK1D",3
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","4/50","92/2914",0.0711127322312037,0.182248710743286,0.126765357111429,"MAPK1/LCK/MAPK3/FGF19",4
"R-HSA-1445148","R-HSA-1445148","Translocation of SLC2A4 (GLUT4) to the plasma membrane","2/50","26/2914",0.0722103447377394,0.182313246615085,0.126810245839595,"YWHAZ/SFN",2
"R-HSA-380320","R-HSA-380320","Recruitment of NuMA to mitotic centrosomes","2/50","26/2914",0.0722103447377394,0.182313246615085,0.126810245839595,"CDK1/CSNK1D",2
"R-HSA-8854518","R-HSA-8854518","AURKA Activation by TPX2","2/50","26/2914",0.0722103447377394,0.182313246615085,0.126810245839595,"CDK1/CSNK1D",2
"R-HSA-380270","R-HSA-380270","Recruitment of mitotic centrosome proteins and complexes","2/50","27/2914",0.0771545482970358,0.188271864265494,0.13095483644473,"CDK1/CSNK1D",2
"R-HSA-380287","R-HSA-380287","Centrosome maturation","2/50","27/2914",0.0771545482970358,0.188271864265494,0.13095483644473,"CDK1/CSNK1D",2
"R-HSA-5617472","R-HSA-5617472","Activation of anterior HOX genes in hindbrain development during early embryogenesis","2/50","27/2914",0.0771545482970358,0.188271864265494,0.13095483644473,"KDM6A/EP300",2
"R-HSA-5619507","R-HSA-5619507","Activation of HOX genes during differentiation","2/50","27/2914",0.0771545482970358,0.188271864265494,0.13095483644473,"KDM6A/EP300",2
"R-HSA-5654732","R-HSA-5654732","Negative regulation of FGFR3 signaling","2/50","27/2914",0.0771545482970358,0.188271864265494,0.13095483644473,"MAPK1/MAPK3",2
"R-HSA-5689896","R-HSA-5689896","Ovarian tumor domain proteases","2/50","27/2914",0.0771545482970358,0.188271864265494,0.13095483644473,"CDK1/TP53",2
"R-HSA-8939236","R-HSA-8939236","RUNX1 regulates transcription of genes involved in differentiation of HSCs","2/50","27/2914",0.0771545482970358,0.188271864265494,0.13095483644473,"YAP1/ABL1",2
"R-HSA-5693567","R-HSA-5693567","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","3/50","59/2914",0.0790723724925504,0.192032904624765,0.13357087483704,"CDK2/CHEK1/ABL1",3
"R-HSA-9006931","R-HSA-9006931","Signaling by Nuclear Receptors","5/50","136/2914",0.0811737486917455,0.194863293959271,0.135539587335964,"MAPK1/MAPK3/HDAC1/EP300/RXRB",5
"R-HSA-114604","R-HSA-114604","GPVI-mediated activation cascade","2/50","28/2914",0.0822035482628072,0.194863293959271,0.135539587335964,"LCK/SYK",2
"R-HSA-4090294","R-HSA-4090294","SUMOylation of intracellular receptors","2/50","28/2914",0.0822035482628072,0.194863293959271,0.135539587335964,"AR/VDR",2
"R-HSA-5620912","R-HSA-5620912","Anchoring of the basal body to the plasma membrane","2/50","28/2914",0.0822035482628072,0.194863293959271,0.135539587335964,"CDK1/CSNK1D",2
"R-HSA-69206","R-HSA-69206","G1/S Transition","3/50","60/2914",0.0822619470058805,0.194863293959271,0.135539587335964,"CDK1/CDK2/HDAC1",3
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","4/50","97/2914",0.0829124211552193,0.194863293959271,0.135539587335964,"NR4A1/GSK3B/LCK/FGF19",4
"R-HSA-913531","R-HSA-913531","Interferon Signaling","4/50","97/2914",0.0829124211552193,0.194863293959271,0.135539587335964,"SOCS3/CIITA/MAPK3/PML",4
"R-HSA-1912422","R-HSA-1912422","Pre-NOTCH Expression and Processing","2/50","29/2914",0.087352462988816,0.204356679469249,0.142142829682429,"TP53/EP300",2
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","4/50","99/2914",0.0878907805599851,0.204677160208185,0.142365744045734,"MAPK1/LCK/MAPK3/FGF19",4
"R-HSA-170834","R-HSA-170834","Signaling by TGF-beta Receptor Complex","3/50","63/2914",0.0921608852874639,0.210822482854647,0.146640199632644,"SMAD3/MEN1/HDAC1",3
"R-HSA-5693538","R-HSA-5693538","Homology Directed Repair","3/50","63/2914",0.0921608852874639,0.210822482854647,0.146640199632644,"CDK2/CHEK1/ABL1",3
"R-HSA-4641262","R-HSA-4641262","Disassembly of the destruction complex and recruitment of AXIN to the membrane","2/50","30/2914",0.0925965414890999,0.210822482854647,0.146640199632644,"GSK3B/AMER1",2
"R-HSA-5633008","R-HSA-5633008","TP53 Regulates Transcription of Cell Death Genes","2/50","30/2914",0.0925965414890999,0.210822482854647,0.146640199632644,"TP53/CASP1",2
"R-HSA-5654726","R-HSA-5654726","Negative regulation of FGFR1 signaling","2/50","30/2914",0.0925965414890999,0.210822482854647,0.146640199632644,"MAPK1/MAPK3",2
"R-HSA-450531","R-HSA-450531","Regulation of mRNA stability by proteins that bind AU-rich elements","2/50","31/2914",0.0979311605383628,0.220995096790111,0.153715887757002,"MAPK11/YWHAZ",2
"R-HSA-4791275","R-HSA-4791275","Signaling by WNT in cancer","2/50","31/2914",0.0979311605383628,0.220995096790111,0.153715887757002,"GSK3B/AMER1",2
"R-HSA-375165","R-HSA-375165","NCAM signaling for neurite out-growth","2/50","32/2914",0.103351821830356,0.230172179622189,0.160099121842472,"MAPK1/MAPK3",2
"R-HSA-5654727","R-HSA-5654727","Negative regulation of FGFR2 signaling","2/50","32/2914",0.103351821830356,0.230172179622189,0.160099121842472,"MAPK1/MAPK3",2
"R-HSA-6802948","R-HSA-6802948","Signaling by high-kinase activity BRAF mutants","2/50","32/2914",0.103351821830356,0.230172179622189,0.160099121842472,"MAPK1/MAPK3",2
"R-HSA-168638","R-HSA-168638","NOD1/2 Signaling Pathway","2/50","33/2914",0.108854149193167,0.241372243863109,0.167889465803648,"CASP1/MAPK11",2
"R-HSA-8939211","R-HSA-8939211","ESR-mediated signaling","4/50","108/2914",0.112043396054315,0.247368536743293,0.172060261883364,"MAPK1/MAPK3/HDAC1/EP300",4
"R-HSA-176408","R-HSA-176408","Regulation of APC/C activators between G1/S and early anaphase","2/50","34/2914",0.114433885860359,0.249407187131552,0.173478270512555,"CDK1/CDK2",2
"R-HSA-5693565","R-HSA-5693565","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks","2/50","34/2914",0.114433885860359,0.249407187131552,0.173478270512555,"TP53/ABL1",2
"R-HSA-6796648","R-HSA-6796648","TP53 Regulates Transcription of DNA Repair Genes","2/50","34/2914",0.114433885860359,0.249407187131552,0.173478270512555,"CHEK1/TP53",2
"R-HSA-76002","R-HSA-76002","Platelet activation, signaling and aggregation","5/50","153/2914",0.119010938886331,0.258279058859697,0.179649211219232,"MAPK1/LCK/MAPK3/YWHAZ/SYK",5
"R-HSA-5693606","R-HSA-5693606","DNA Double Strand Break Response","2/50","35/2914",0.120086891796919,0.25950980854419,0.180505274467269,"TP53/ABL1",2
"R-HSA-5621481","R-HSA-5621481","C-type lectin receptors (CLRs)","3/50","72/2914",0.124605897668289,0.268139273463407,0.186507606103546,"EP300/SYK/FBXW11",3
"R-HSA-1643685","R-HSA-1643685","Disease","11/50","443/2914",0.126645544675443,0.271383310018806,0.188764036070872,"MAPK1/SMAD3/NR4A1/GSK3B/LCK/AMER1/MAPK3/HDAC1/EP300/FGF19/STAT3",11
"R-HSA-73894","R-HSA-73894","DNA Repair","5/50","157/2914",0.128976913223178,0.275222701856992,0.191434572808682,"CDK2/CHEK1/TP53/EP300/ABL1",5
"R-HSA-5654741","R-HSA-5654741","Signaling by FGFR3","2/50","37/2914",0.131596719326343,0.279643028568478,0.194509186021831,"MAPK1/MAPK3",2
"R-HSA-556833","R-HSA-556833","Metabolism of lipids","4/50","119/2914",0.145160756463678,0.307186663055916,0.21366750350845,"CSNK2A1/VDR/EP300/RXRB",4
"R-HSA-174143","R-HSA-174143","APC/C-mediated degradation of cell cycle proteins","2/50","40/2914",0.14931390473803,0.312090538591784,0.217078455119569,"CDK1/CDK2",2
"R-HSA-2122947","R-HSA-2122947","NOTCH1 Intracellular Domain Regulates Transcription","2/50","40/2914",0.14931390473803,0.312090538591784,0.217078455119569,"HDAC1/EP300",2
"R-HSA-453276","R-HSA-453276","Regulation of mitotic cell cycle","2/50","40/2914",0.14931390473803,0.312090538591784,0.217078455119569,"CDK1/CDK2",2
"R-HSA-5654736","R-HSA-5654736","Signaling by FGFR1","2/50","41/2914",0.155325798928623,0.31901693369862,0.221896195369318,"MAPK1/MAPK3",2
"R-HSA-1852241","R-HSA-1852241","Organelle biogenesis and maintenance","3/50","80/2914",0.156450029452832,0.31901693369862,0.221896195369318,"CDK1/MAPK11/CSNK1D",3
"R-HSA-5689880","R-HSA-5689880","Ub-specific processing proteases","3/50","80/2914",0.156450029452832,0.31901693369862,0.221896195369318,"AR/SMAD3/TP53",3
"R-HSA-164938","R-HSA-164938","Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters","1/50","10/2914",0.159152342017196,0.31901693369862,0.221896195369318,"LCK",1
"R-HSA-2029481","R-HSA-2029481","FCGR activation","1/50","10/2914",0.159152342017196,0.31901693369862,0.221896195369318,"SYK",1
"R-HSA-6804759","R-HSA-6804759","Regulation of TP53 Activity through Association with Co-factors","1/50","10/2914",0.159152342017196,0.31901693369862,0.221896195369318,"TP53",1
"R-HSA-8934903","R-HSA-8934903","Receptor Mediated Mitophagy","1/50","10/2914",0.159152342017196,0.31901693369862,0.221896195369318,"CSNK2A1",1
"R-HSA-9020956","R-HSA-9020956","Interleukin-27 signaling","1/50","10/2914",0.159152342017196,0.31901693369862,0.221896195369318,"STAT3",1
"R-HSA-9020958","R-HSA-9020958","Interleukin-21 signaling","1/50","10/2914",0.159152342017196,0.31901693369862,0.221896195369318,"STAT3",1
"R-HSA-5617833","R-HSA-5617833","Cilium Assembly","2/50","42/2914",0.161385037047537,0.31901693369862,0.221896195369318,"CDK1/CSNK1D",2
"R-HSA-6802946","R-HSA-6802946","Signaling by moderate kinase activity BRAF mutants","2/50","42/2914",0.161385037047537,0.31901693369862,0.221896195369318,"MAPK1/MAPK3",2
"R-HSA-6802949","R-HSA-6802949","Signaling by RAS mutants","2/50","42/2914",0.161385037047537,0.31901693369862,0.221896195369318,"MAPK1/MAPK3",2
"R-HSA-6802955","R-HSA-6802955","Paradoxical activation of RAF signaling by kinase inactive BRAF","2/50","42/2914",0.161385037047537,0.31901693369862,0.221896195369318,"MAPK1/MAPK3",2
"R-HSA-9649948","R-HSA-9649948","Signaling downstream of RAS mutants","2/50","42/2914",0.161385037047537,0.31901693369862,0.221896195369318,"MAPK1/MAPK3",2
"R-HSA-202424","R-HSA-202424","Downstream TCR signaling","2/50","43/2914",0.167488322892432,0.323682502479642,0.225141389753642,"LCK/FBXW11",2
"R-HSA-113510","R-HSA-113510","E2F mediated regulation of DNA replication","1/50","11/2914",0.173629746596789,0.323682502479642,0.225141389753642,"CDK1",1
"R-HSA-1362277","R-HSA-1362277","Transcription of E2F targets under negative control by DREAM complex","1/50","11/2914",0.173629746596789,0.323682502479642,0.225141389753642,"HDAC1",1
"R-HSA-210990","R-HSA-210990","PECAM1 interactions","1/50","11/2914",0.173629746596789,0.323682502479642,0.225141389753642,"LCK",1
"R-HSA-2197563","R-HSA-2197563","NOTCH2 intracellular domain regulates transcription","1/50","11/2914",0.173629746596789,0.323682502479642,0.225141389753642,"EP300",1
"R-HSA-3371568","R-HSA-3371568","Attenuation phase","1/50","11/2914",0.173629746596789,0.323682502479642,0.225141389753642,"EP300",1
"R-HSA-349425","R-HSA-349425","Autodegradation of the E3 ubiquitin ligase COP1","1/50","11/2914",0.173629746596789,0.323682502479642,0.225141389753642,"TP53",1
"R-HSA-452723","R-HSA-452723","Transcriptional regulation of pluripotent stem cells","1/50","11/2914",0.173629746596789,0.323682502479642,0.225141389753642,"STAT3",1
"R-HSA-69601","R-HSA-69601","Ubiquitin Mediated Degradation of Phosphorylated Cdc25A","1/50","11/2914",0.173629746596789,0.323682502479642,0.225141389753642,"CHEK1",1
"R-HSA-69610","R-HSA-69610","p53-Independent DNA Damage Response","1/50","11/2914",0.173629746596789,0.323682502479642,0.225141389753642,"CHEK1",1
"R-HSA-69613","R-HSA-69613","p53-Independent G1/S DNA damage checkpoint","1/50","11/2914",0.173629746596789,0.323682502479642,0.225141389753642,"CHEK1",1
"R-HSA-75815","R-HSA-75815","Ubiquitin-dependent degradation of Cyclin D","1/50","11/2914",0.173629746596789,0.323682502479642,0.225141389753642,"GSK3B",1
"R-HSA-8984722","R-HSA-8984722","Interleukin-35 Signalling","1/50","11/2914",0.173629746596789,0.323682502479642,0.225141389753642,"STAT3",1
"R-HSA-9013700","R-HSA-9013700","NOTCH4 Activation and Transmission of Signal to the Nucleus","1/50","11/2914",0.173629746596789,0.323682502479642,0.225141389753642,"YWHAZ",1
"R-HSA-512988","R-HSA-512988","Interleukin-3, Interleukin-5 and GM-CSF signaling","2/50","45/2914",0.179814325612306,0.323682502479642,0.225141389753642,"YWHAZ/SYK",2
"R-HSA-9006936","R-HSA-9006936","Signaling by TGF-beta family members","3/50","86/2914",0.181854584721852,0.323682502479642,0.225141389753642,"SMAD3/MEN1/HDAC1",3
"R-HSA-6802952","R-HSA-6802952","Signaling by BRAF and RAF fusions","2/50","46/2914",0.186030916250395,0.323682502479642,0.225141389753642,"MAPK1/MAPK3",2
"R-HSA-1483206","R-HSA-1483206","Glycerophospholipid biosynthesis","1/50","12/2914",0.187862785752891,0.323682502479642,0.225141389753642,"CSNK2A1",1
"R-HSA-1502540","R-HSA-1502540","Signaling by Activin","1/50","12/2914",0.187862785752891,0.323682502479642,0.225141389753642,"SMAD3",1
"R-HSA-1839117","R-HSA-1839117","Signaling by cytosolic FGFR1 fusion mutants","1/50","12/2914",0.187862785752891,0.323682502479642,0.225141389753642,"STAT3",1
"R-HSA-202427","R-HSA-202427","Phosphorylation of CD3 and TCR zeta chains","1/50","12/2914",0.187862785752891,0.323682502479642,0.225141389753642,"LCK",1
"R-HSA-2032785","R-HSA-2032785","YAP1- and WWTR1 (TAZ)-stimulated gene expression","1/50","12/2914",0.187862785752891,0.323682502479642,0.225141389753642,"YAP1",1
"R-HSA-204005","R-HSA-204005","COPII-mediated vesicle transport","1/50","12/2914",0.187862785752891,0.323682502479642,0.225141389753642,"CSNK1D",1
"R-HSA-210744","R-HSA-210744","Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells","1/50","12/2914",0.187862785752891,0.323682502479642,0.225141389753642,"EP300",1
"R-HSA-3301854","R-HSA-3301854","Nuclear Pore Complex (NPC) Disassembly","1/50","12/2914",0.187862785752891,0.323682502479642,0.225141389753642,"CDK1",1
"R-HSA-389359","R-HSA-389359","CD28 dependent Vav1 pathway","1/50","12/2914",0.187862785752891,0.323682502479642,0.225141389753642,"LCK",1
"R-HSA-389948","R-HSA-389948","PD-1 signaling","1/50","12/2914",0.187862785752891,0.323682502479642,0.225141389753642,"LCK",1
"R-HSA-418990","R-HSA-418990","Adherens junctions interactions","1/50","12/2914",0.187862785752891,0.323682502479642,0.225141389753642,"CTNNA1",1
"R-HSA-5362517","R-HSA-5362517","Signaling by Retinoic Acid","1/50","12/2914",0.187862785752891,0.323682502479642,0.225141389753642,"RXRB",1
"R-HSA-6791226","R-HSA-6791226","Major pathway of rRNA processing in the nucleolus and cytosol","1/50","12/2914",0.187862785752891,0.323682502479642,0.225141389753642,"CSNK1D",1
"R-HSA-68962","R-HSA-68962","Activation of the pre-replicative complex","1/50","12/2914",0.187862785752891,0.323682502479642,0.225141389753642,"CDK2",1
"R-HSA-72312","R-HSA-72312","rRNA processing","1/50","12/2914",0.187862785752891,0.323682502479642,0.225141389753642,"CSNK1D",1
"R-HSA-844456","R-HSA-844456","The NLRP3 inflammasome","1/50","12/2914",0.187862785752891,0.323682502479642,0.225141389753642,"CASP1",1
"R-HSA-8868773","R-HSA-8868773","rRNA processing in the nucleus and cytosol","1/50","12/2914",0.187862785752891,0.323682502479642,0.225141389753642,"CSNK1D",1
"R-HSA-9005891","R-HSA-9005891","Loss of function of MECP2 in Rett syndrome","1/50","12/2914",0.187862785752891,0.323682502479642,0.225141389753642,"HDAC1",1
"R-HSA-9005895","R-HSA-9005895","Pervasive developmental disorders","1/50","12/2914",0.187862785752891,0.323682502479642,0.225141389753642,"HDAC1",1
"R-HSA-9022699","R-HSA-9022699","MECP2 regulates neuronal receptors and channels","1/50","12/2914",0.187862785752891,0.323682502479642,0.225141389753642,"HDAC1",1
"R-HSA-9639288","R-HSA-9639288","Amino acids regulate mTORC1","1/50","12/2914",0.187862785752891,0.323682502479642,0.225141389753642,"LAMTOR3",1
"R-HSA-983168","R-HSA-983168","Antigen processing: Ubiquitination & Proteasome degradation","3/50","88/2914",0.190568234630066,0.327238382698093,0.227614726458735,"SOCS3/FBXO22/FBXW11",3
"R-HSA-1989781","R-HSA-1989781","PPARA activates gene expression","2/50","47/2914",0.192279297914528,0.327968033232138,0.22812224396126,"EP300/RXRB",2
"R-HSA-438064","R-HSA-438064","Post NMDA receptor activation events","2/50","47/2914",0.192279297914528,0.327968033232138,0.22812224396126,"MAPK1/MAPK3",2
"R-HSA-168643","R-HSA-168643","Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways","2/50","48/2914",0.198556627890006,0.332084857087764,0.230985751988806,"CASP1/MAPK11",2
"R-HSA-400206","R-HSA-400206","Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)","2/50","48/2914",0.198556627890006,0.332084857087764,0.230985751988806,"EP300/RXRB",2
"R-HSA-5693607","R-HSA-5693607","Processing of DNA double-strand break ends","2/50","48/2914",0.198556627890006,0.332084857087764,0.230985751988806,"CDK2/CHEK1",2
"R-HSA-1368082","R-HSA-1368082","RORA activates gene expression","1/50","13/2914",0.201855501367072,0.332084857087764,0.230985751988806,"EP300",1
"R-HSA-171007","R-HSA-171007","p38MAPK events","1/50","13/2914",0.201855501367072,0.332084857087764,0.230985751988806,"MAPK11",1
"R-HSA-190322","R-HSA-190322","FGFR4 ligand binding and activation","1/50","13/2914",0.201855501367072,0.332084857087764,0.230985751988806,"FGF19",1
"R-HSA-198323","R-HSA-198323","AKT phosphorylates targets in the cytosol","1/50","13/2914",0.201855501367072,0.332084857087764,0.230985751988806,"GSK3B",1
"R-HSA-5689901","R-HSA-5689901","Metalloprotease DUBs","1/50","13/2914",0.201855501367072,0.332084857087764,0.230985751988806,"EP300",1
"R-HSA-8941856","R-HSA-8941856","RUNX3 regulates NOTCH signaling","1/50","13/2914",0.201855501367072,0.332084857087764,0.230985751988806,"EP300",1
"R-HSA-912446","R-HSA-912446","Meiotic recombination","1/50","13/2914",0.201855501367072,0.332084857087764,0.230985751988806,"CDK2",1
"R-HSA-9614657","R-HSA-9614657","FOXO-mediated transcription of cell death genes","1/50","13/2914",0.201855501367072,0.332084857087764,0.230985751988806,"EP300",1
"R-HSA-442755","R-HSA-442755","Activation of NMDA receptors and postsynaptic events","2/50","49/2914",0.204860147969908,0.333797685190585,0.232177130875598,"MAPK1/MAPK3",2
"R-HSA-6802957","R-HSA-6802957","Oncogenic MAPK signaling","2/50","49/2914",0.204860147969908,0.333797685190585,0.232177130875598,"MAPK1/MAPK3",2
"R-HSA-9018519","R-HSA-9018519","Estrogen-dependent gene expression","2/50","49/2914",0.204860147969908,0.333797685190585,0.232177130875598,"HDAC1/EP300",2
"R-HSA-5654738","R-HSA-5654738","Signaling by FGFR2","2/50","50/2914",0.211187182489899,0.340315704189477,0.236710820045105,"MAPK1/MAPK3",2
"R-HSA-5654228","R-HSA-5654228","Phospholipase C-mediated cascade; FGFR4","1/50","14/2914",0.215611869837133,0.340315704189477,0.236710820045105,"FGF19",1
"R-HSA-5684264","R-HSA-5684264","MAP3K8 (TPL2)-dependent MAPK1/3 activation","1/50","14/2914",0.215611869837133,0.340315704189477,0.236710820045105,"FBXW11",1
"R-HSA-877312","R-HSA-877312","Regulation of IFNG signaling","1/50","14/2914",0.215611869837133,0.340315704189477,0.236710820045105,"SOCS3",1
"R-HSA-8983432","R-HSA-8983432","Interleukin-15 signaling","1/50","14/2914",0.215611869837133,0.340315704189477,0.236710820045105,"STAT3",1
"R-HSA-918233","R-HSA-918233","TRAF3-dependent IRF activation pathway","1/50","14/2914",0.215611869837133,0.340315704189477,0.236710820045105,"EP300",1
"R-HSA-9617828","R-HSA-9617828","FOXO-mediated transcription of cell cycle genes","1/50","14/2914",0.215611869837133,0.340315704189477,0.236710820045105,"SMAD3",1
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","3/50","94/2914",0.217331378590586,0.340315704189477,0.236710820045105,"SOCS3/TP53/STAT3",3
"R-HSA-2644602","R-HSA-2644602","Signaling by NOTCH1 PEST Domain Mutants in Cancer","2/50","51/2914",0.217535136403469,0.340315704189477,0.236710820045105,"HDAC1/EP300",2
"R-HSA-2644603","R-HSA-2644603","Signaling by NOTCH1 in Cancer","2/50","51/2914",0.217535136403469,0.340315704189477,0.236710820045105,"HDAC1/EP300",2
"R-HSA-2644606","R-HSA-2644606","Constitutive Signaling by NOTCH1 PEST Domain Mutants","2/50","51/2914",0.217535136403469,0.340315704189477,0.236710820045105,"HDAC1/EP300",2
"R-HSA-2894858","R-HSA-2894858","Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer","2/50","51/2914",0.217535136403469,0.340315704189477,0.236710820045105,"HDAC1/EP300",2
"R-HSA-2894862","R-HSA-2894862","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants","2/50","51/2914",0.217535136403469,0.340315704189477,0.236710820045105,"HDAC1/EP300",2
"R-HSA-1181150","R-HSA-1181150","Signaling by NODAL","1/50","15/2914",0.229135803115803,0.34644467599361,0.240973902600303,"SMAD3",1
"R-HSA-1433559","R-HSA-1433559","Regulation of KIT signaling","1/50","15/2914",0.229135803115803,0.34644467599361,0.240973902600303,"LCK",1
"R-HSA-176412","R-HSA-176412","Phosphorylation of the APC/C","1/50","15/2914",0.229135803115803,0.34644467599361,0.240973902600303,"CDK1",1
"R-HSA-2730905","R-HSA-2730905","Role of LAT2/NTAL/LAB on calcium mobilization","1/50","15/2914",0.229135803115803,0.34644467599361,0.240973902600303,"SYK",1
"R-HSA-3214842","R-HSA-3214842","HDMs demethylate histones","1/50","15/2914",0.229135803115803,0.34644467599361,0.240973902600303,"KDM6A",1
"R-HSA-3371497","R-HSA-3371497","HSP90 chaperone cycle for steroid hormone receptors (SHR)","1/50","15/2914",0.229135803115803,0.34644467599361,0.240973902600303,"AR",1
"R-HSA-392517","R-HSA-392517","Rap1 signalling","1/50","15/2914",0.229135803115803,0.34644467599361,0.240973902600303,"YWHAZ",1
"R-HSA-427413","R-HSA-427413","NoRC negatively regulates rRNA expression","1/50","15/2914",0.229135803115803,0.34644467599361,0.240973902600303,"HDAC1",1
"R-HSA-6803204","R-HSA-6803204","TP53 Regulates Transcription of Genes Involved in Cytochrome C Release","1/50","15/2914",0.229135803115803,0.34644467599361,0.240973902600303,"TP53",1
"R-HSA-69541","R-HSA-69541","Stabilization of p53","1/50","15/2914",0.229135803115803,0.34644467599361,0.240973902600303,"TP53",1
"R-HSA-9604323","R-HSA-9604323","Negative regulation of NOTCH4 signaling","1/50","15/2914",0.229135803115803,0.34644467599361,0.240973902600303,"YWHAZ",1
"R-HSA-1632852","R-HSA-1632852","Macroautophagy","2/50","53/2914",0.230283814042811,0.34644467599361,0.240973902600303,"CSNK2A1/LAMTOR3",2
"R-HSA-5607764","R-HSA-5607764","CLEC7A (Dectin-1) signaling","2/50","53/2914",0.230283814042811,0.34644467599361,0.240973902600303,"SYK/FBXW11",2
"R-HSA-166208","R-HSA-166208","mTORC1-mediated signalling","1/50","16/2914",0.24243114973333,0.357340712034677,0.248552775966328,"LAMTOR3",1
"R-HSA-3214815","R-HSA-3214815","HDACs deacetylate histones","1/50","16/2914",0.24243114973333,0.357340712034677,0.248552775966328,"HDAC1",1
"R-HSA-3232118","R-HSA-3232118","SUMOylation of transcription factors","1/50","16/2914",0.24243114973333,0.357340712034677,0.248552775966328,"TP53",1
"R-HSA-5205647","R-HSA-5205647","Mitophagy","1/50","16/2914",0.24243114973333,0.357340712034677,0.248552775966328,"CSNK2A1",1
"R-HSA-5676590","R-HSA-5676590","NIK-->noncanonical NF-kB signaling","1/50","16/2914",0.24243114973333,0.357340712034677,0.248552775966328,"FBXW11",1
"R-HSA-622312","R-HSA-622312","Inflammasomes","1/50","16/2914",0.24243114973333,0.357340712034677,0.248552775966328,"CASP1",1
"R-HSA-8941858","R-HSA-8941858","Regulation of RUNX3 expression and activity","1/50","16/2914",0.24243114973333,0.357340712034677,0.248552775966328,"EP300",1
"R-HSA-164952","R-HSA-164952","The role of Nef in HIV-1 replication and disease pathogenesis","1/50","17/2914",0.255501695804183,0.370187116079924,0.257488252051464,"LCK",1
"R-HSA-174048","R-HSA-174048","APC/C:Cdc20 mediated degradation of Cyclin B","1/50","17/2914",0.255501695804183,0.370187116079924,0.257488252051464,"CDK1",1
"R-HSA-2029485","R-HSA-2029485","Role of phospholipids in phagocytosis","1/50","17/2914",0.255501695804183,0.370187116079924,0.257488252051464,"SYK",1
"R-HSA-3232142","R-HSA-3232142","SUMOylation of ubiquitinylation proteins","1/50","17/2914",0.255501695804183,0.370187116079924,0.257488252051464,"PML",1
"R-HSA-5607761","R-HSA-5607761","Dectin-1 mediated noncanonical NF-kB signaling","1/50","17/2914",0.255501695804183,0.370187116079924,0.257488252051464,"FBXW11",1
"R-HSA-68949","R-HSA-68949","Orc1 removal from chromatin","1/50","17/2914",0.255501695804183,0.370187116079924,0.257488252051464,"CDK2",1
"R-HSA-422475","R-HSA-422475","Axon guidance","6/50","254/2914",0.266814887717219,0.38184027673815,0.265593752860178,"MAPK1/CSNK2A1/GSK3B/MAPK11/MAPK3/ABL1",6
"R-HSA-202433","R-HSA-202433","Generation of second messenger molecules","1/50","18/2914",0.268351166018126,0.38184027673815,0.265593752860178,"LCK",1
"R-HSA-380972","R-HSA-380972","Energy dependent regulation of mTOR by LKB1-AMPK","1/50","18/2914",0.268351166018126,0.38184027673815,0.265593752860178,"LAMTOR3",1
"R-HSA-5610783","R-HSA-5610783","Degradation of GLI2 by the proteasome","1/50","18/2914",0.268351166018126,0.38184027673815,0.265593752860178,"GSK3B",1
"R-HSA-8953750","R-HSA-8953750","Transcriptional Regulation by E2F6","1/50","18/2914",0.268351166018126,0.38184027673815,0.265593752860178,"CHEK1",1
"R-HSA-9013508","R-HSA-9013508","NOTCH3 Intracellular Domain Regulates Transcription","1/50","18/2914",0.268351166018126,0.38184027673815,0.265593752860178,"EP300",1
"R-HSA-202403","R-HSA-202403","TCR signaling","2/50","59/2914",0.268785606566658,0.38184027673815,0.265593752860178,"LCK/FBXW11",2
"R-HSA-2980766","R-HSA-2980766","Nuclear Envelope Breakdown","1/50","19/2914",0.280983224615879,0.388217946465517,0.270029820348564,"CDK1",1
"R-HSA-3371571","R-HSA-3371571","HSF1-dependent transactivation","1/50","19/2914",0.280983224615879,0.388217946465517,0.270029820348564,"EP300",1
"R-HSA-389513","R-HSA-389513","CTLA4 inhibitory signaling","1/50","19/2914",0.280983224615879,0.388217946465517,0.270029820348564,"LCK",1
"R-HSA-421270","R-HSA-421270","Cell-cell junction organization","1/50","19/2914",0.280983224615879,0.388217946465517,0.270029820348564,"CTNNA1",1
"R-HSA-5610785","R-HSA-5610785","GLI3 is processed to GLI3R by the proteasome","1/50","19/2914",0.280983224615879,0.388217946465517,0.270029820348564,"GSK3B",1
"R-HSA-5621575","R-HSA-5621575","CD209 (DC-SIGN) signaling","1/50","19/2914",0.280983224615879,0.388217946465517,0.270029820348564,"EP300",1
"R-HSA-5654719","R-HSA-5654719","SHC-mediated cascade:FGFR4","1/50","19/2914",0.280983224615879,0.388217946465517,0.270029820348564,"FGF19",1
"R-HSA-5654720","R-HSA-5654720","PI-3K cascade:FGFR4","1/50","19/2914",0.280983224615879,0.388217946465517,0.270029820348564,"FGF19",1
"R-HSA-6814122","R-HSA-6814122","Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding","1/50","19/2914",0.280983224615879,0.388217946465517,0.270029820348564,"CSNK2A1",1
"R-HSA-73762","R-HSA-73762","RNA Polymerase I Transcription Initiation","1/50","19/2914",0.280983224615879,0.388217946465517,0.270029820348564,"HDAC1",1
"R-HSA-9612973","R-HSA-9612973","Autophagy","2/50","61/2914",0.281648314102434,0.388217946465517,0.270029820348564,"CSNK2A1/LAMTOR3",2
"R-HSA-3247509","R-HSA-3247509","Chromatin modifying enzymes","3/50","109/2914",0.287150574733599,0.39261874829527,0.273090852787422,"KDM6A/HDAC1/EP300",3
"R-HSA-4839726","R-HSA-4839726","Chromatin organization","3/50","109/2914",0.287150574733599,0.39261874829527,0.273090852787422,"KDM6A/HDAC1/EP300",3
"R-HSA-8953854","R-HSA-8953854","Metabolism of RNA","3/50","109/2914",0.287150574733599,0.39261874829527,0.273090852787422,"MAPK11/CSNK1D/YWHAZ",3
"R-HSA-167044","R-HSA-167044","Signalling to RAS","1/50","20/2914",0.293401476349629,0.39524974728761,0.274920876854333,"MAPK11",1
"R-HSA-199977","R-HSA-199977","ER to Golgi Anterograde Transport","1/50","20/2914",0.293401476349629,0.39524974728761,0.274920876854333,"CSNK1D",1
"R-HSA-437239","R-HSA-437239","Recycling pathway of L1","1/50","20/2914",0.293401476349629,0.39524974728761,0.274920876854333,"MAPK1",1
"R-HSA-450321","R-HSA-450321","JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1","1/50","20/2914",0.293401476349629,0.39524974728761,0.274920876854333,"MAPK9",1
"R-HSA-912631","R-HSA-912631","Regulation of signaling by CBL","1/50","20/2914",0.293401476349629,0.39524974728761,0.274920876854333,"SYK",1
"R-HSA-9009391","R-HSA-9009391","Extra-nuclear estrogen signaling","2/50","63/2914",0.294499811704494,0.39524974728761,0.274920876854333,"MAPK1/MAPK3",2
"R-HSA-983705","R-HSA-983705","Signaling by the B Cell Receptor (BCR)","2/50","63/2914",0.294499811704494,0.39524974728761,0.274920876854333,"SYK/FBXW11",2
"R-HSA-1980143","R-HSA-1980143","Signaling by NOTCH1","2/50","64/2914",0.300916982937529,0.402802260625039,0.280174121425466,"HDAC1/EP300",2
"R-HSA-111465","R-HSA-111465","Apoptotic cleavage of cellular proteins","1/50","21/2914",0.305609467428592,0.404833320489823,0.281586850371662,"TJP2",1
"R-HSA-389357","R-HSA-389357","CD28 dependent PI3K/Akt signaling","1/50","21/2914",0.305609467428592,0.404833320489823,0.281586850371662,"LCK",1
"R-HSA-450302","R-HSA-450302","activated TAK1 mediates p38 MAPK activation","1/50","21/2914",0.305609467428592,0.404833320489823,0.281586850371662,"MAPK11",1
"R-HSA-5654712","R-HSA-5654712","FRS-mediated FGFR4 signaling","1/50","21/2914",0.305609467428592,0.404833320489823,0.281586850371662,"FGF19",1
"R-HSA-983169","R-HSA-983169","Class I MHC mediated antigen processing & presentation","3/50","115/2914",0.315729197009537,0.414274808412879,0.288153994706172,"SOCS3/FBXO22/FBXW11",3
"R-HSA-1266695","R-HSA-1266695","Interleukin-7 signaling","1/50","22/2914",0.317610686449874,0.414274808412879,0.288153994706172,"STAT3",1
"R-HSA-1500620","R-HSA-1500620","Meiosis","1/50","22/2914",0.317610686449874,0.414274808412879,0.288153994706172,"CDK2",1
"R-HSA-187577","R-HSA-187577","SCF(Skp2)-mediated degradation of p27/p21","1/50","22/2914",0.317610686449874,0.414274808412879,0.288153994706172,"CDK2",1
"R-HSA-2173788","R-HSA-2173788","Downregulation of TGF-beta receptor signaling","1/50","22/2914",0.317610686449874,0.414274808412879,0.288153994706172,"SMAD3",1
"R-HSA-9022692","R-HSA-9022692","Regulation of MECP2 expression and activity","1/50","22/2914",0.317610686449874,0.414274808412879,0.288153994706172,"HDAC1",1
"R-HSA-4551638","R-HSA-4551638","SUMOylation of chromatin organization proteins","1/50","23/2914",0.329408565314849,0.424238303814578,0.295084227833875,"HDAC1",1
"R-HSA-5685938","R-HSA-5685938","HDR through Single Strand Annealing (SSA)","1/50","23/2914",0.329408565314849,0.424238303814578,0.295084227833875,"ABL1",1
"R-HSA-5693616","R-HSA-5693616","Presynaptic phase of homologous DNA pairing and strand exchange","1/50","23/2914",0.329408565314849,0.424238303814578,0.295084227833875,"CHEK1",1
"R-HSA-69002","R-HSA-69002","DNA Replication Pre-Initiation","1/50","23/2914",0.329408565314849,0.424238303814578,0.295084227833875,"CDK2",1
"R-HSA-948021","R-HSA-948021","Transport to the Golgi and subsequent modification","1/50","23/2914",0.329408565314849,0.424238303814578,0.295084227833875,"CSNK1D",1
"R-HSA-1169091","R-HSA-1169091","Activation of NF-kappaB in B cells","1/50","24/2914",0.341006480131264,0.430478477393428,0.299424658166326,"FBXW11",1
"R-HSA-1234174","R-HSA-1234174","Cellular response to hypoxia","1/50","24/2914",0.341006480131264,0.430478477393428,0.299424658166326,"EP300",1
"R-HSA-1474165","R-HSA-1474165","Reproduction","1/50","24/2914",0.341006480131264,0.430478477393428,0.299424658166326,"CDK2",1
"R-HSA-1839124","R-HSA-1839124","FGFR1 mutant receptor activation","1/50","24/2914",0.341006480131264,0.430478477393428,0.299424658166326,"STAT3",1
"R-HSA-186712","R-HSA-186712","Regulation of beta-cell development","1/50","24/2914",0.341006480131264,0.430478477393428,0.299424658166326,"EP300",1
"R-HSA-5693579","R-HSA-5693579","Homologous DNA Pairing and Strand Exchange","1/50","24/2914",0.341006480131264,0.430478477393428,0.299424658166326,"CHEK1",1
"R-HSA-8854691","R-HSA-8854691","Interleukin-20 family signaling","1/50","24/2914",0.341006480131264,0.430478477393428,0.299424658166326,"STAT3",1
"R-HSA-912694","R-HSA-912694","Regulation of IFNA signaling","1/50","24/2914",0.341006480131264,0.430478477393428,0.299424658166326,"SOCS3",1
"R-HSA-69242","R-HSA-69242","S Phase","2/50","71/2914",0.345529653263223,0.435111415220355,0.302647155684746,"CDK2/GSK3B",2
"R-HSA-2219530","R-HSA-2219530","Constitutive Signaling by Aberrant PI3K in Cancer","2/50","72/2914",0.351841760565935,0.437294290928635,0.304165482028792,"LCK/FGF19",2
"R-HSA-354192","R-HSA-354192","Integrin alphaIIb beta3 signaling","1/50","25/2914",0.352407752101312,0.437294290928635,0.304165482028792,"SYK",1
"R-HSA-5218920","R-HSA-5218920","VEGFR2 mediated vascular permeability","1/50","25/2914",0.352407752101312,0.437294290928635,0.304165482028792,"CTNNA1",1
"R-HSA-8864260","R-HSA-8864260","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","1/50","25/2914",0.352407752101312,0.437294290928635,0.304165482028792,"EP300",1
"R-HSA-8948751","R-HSA-8948751","Regulation of PTEN stability and activity","1/50","25/2914",0.352407752101312,0.437294290928635,0.304165482028792,"CSNK2A1",1
"R-HSA-9006921","R-HSA-9006921","Integrin signaling","1/50","25/2914",0.352407752101312,0.437294290928635,0.304165482028792,"SYK",1
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","3/50","125/2914",0.363517766834633,0.44470978580788,0.309323421707442,"MAPK1/LAMTOR3/PTPRB",3
"R-HSA-111996","R-HSA-111996","Ca-dependent events","1/50","26/2914",0.363615648395855,0.44470978580788,0.309323421707442,"MAPK1",1
"R-HSA-350054","R-HSA-350054","Notch-HLH transcription pathway","1/50","26/2914",0.363615648395855,0.44470978580788,0.309323421707442,"HDAC1",1
"R-HSA-5654716","R-HSA-5654716","Downstream signaling of activated FGFR4","1/50","26/2914",0.363615648395855,0.44470978580788,0.309323421707442,"FGF19",1
"R-HSA-75153","R-HSA-75153","Apoptotic execution phase","1/50","26/2914",0.363615648395855,0.44470978580788,0.309323421707442,"TJP2",1
"R-HSA-8939902","R-HSA-8939902","Regulation of RUNX2 expression and activity","1/50","26/2914",0.363615648395855,0.44470978580788,0.309323421707442,"GSK3B",1
"R-HSA-1251985","R-HSA-1251985","Nuclear signaling by ERBB4","1/50","27/2914",0.37463338301504,0.452755984212489,0.314920055066272,"YAP1",1
"R-HSA-165159","R-HSA-165159","mTOR signalling","1/50","27/2914",0.37463338301504,0.452755984212489,0.314920055066272,"LAMTOR3",1
"R-HSA-174184","R-HSA-174184","Cdc20:Phospho-APC/C mediated degradation of Cyclin A","1/50","27/2914",0.37463338301504,0.452755984212489,0.314920055066272,"CDK1",1
"R-HSA-69017","R-HSA-69017","CDK-mediated phosphorylation and removal of Cdc6","1/50","27/2914",0.37463338301504,0.452755984212489,0.314920055066272,"CDK2",1
"R-HSA-983695","R-HSA-983695","Antigen activates B Cell Receptor (BCR) leading to generation of second messengers","1/50","27/2914",0.37463338301504,0.452755984212489,0.314920055066272,"SYK",1
"R-HSA-112314","R-HSA-112314","Neurotransmitter receptors and postsynaptic signal transmission","2/50","77/2914",0.383091062014488,0.459314719612387,0.319482065034828,"MAPK1/MAPK3",2
"R-HSA-179419","R-HSA-179419","APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint","1/50","28/2914",0.385464117635493,0.459314719612387,0.319482065034828,"CDK1",1
"R-HSA-2173789","R-HSA-2173789","TGF-beta receptor signaling activates SMADs","1/50","28/2914",0.385464117635493,0.459314719612387,0.319482065034828,"SMAD3",1
"R-HSA-6781823","R-HSA-6781823","Formation of TC-NER Pre-Incision Complex","1/50","28/2914",0.385464117635493,0.459314719612387,0.319482065034828,"EP300",1
"R-HSA-8957322","R-HSA-8957322","Metabolism of steroids","1/50","28/2914",0.385464117635493,0.459314719612387,0.319482065034828,"VDR",1
"R-HSA-933541","R-HSA-933541","TRAF6 mediated IRF7 activation","1/50","28/2914",0.385464117635493,0.459314719612387,0.319482065034828,"EP300",1
"R-HSA-176409","R-HSA-176409","APC/C:Cdc20 mediated degradation of mitotic proteins","1/50","29/2914",0.396110962444303,0.46763099733008,0.325266555418446,"CDK1",1
"R-HSA-186763","R-HSA-186763","Downstream signal transduction","1/50","29/2914",0.396110962444303,0.46763099733008,0.325266555418446,"STAT3",1
"R-HSA-1980145","R-HSA-1980145","Signaling by NOTCH2","1/50","29/2914",0.396110962444303,0.46763099733008,0.325266555418446,"EP300",1
"R-HSA-2871809","R-HSA-2871809","FCERI mediated Ca+2 mobilization","1/50","29/2914",0.396110962444303,0.46763099733008,0.325266555418446,"SYK",1
"R-HSA-1280218","R-HSA-1280218","Adaptive Immune System","6/50","296/2914",0.398442369548765,0.469297017251432,0.326425376292534,"SOCS3/FBXO22/LCK/YWHAZ/SYK/FBXW11",6
"R-HSA-1483257","R-HSA-1483257","Phospholipid metabolism","1/50","30/2914",0.406576976959999,0.476676455746206,0.331558236504585,"CSNK2A1",1
"R-HSA-176814","R-HSA-176814","Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins","1/50","30/2914",0.406576976959999,0.476676455746206,0.331558236504585,"CDK1",1
"R-HSA-389356","R-HSA-389356","CD28 co-stimulation","1/50","31/2914",0.416865170840721,0.486501686793518,0.338392298141209,"LCK",1
"R-HSA-5655302","R-HSA-5655302","Signaling by FGFR1 in disease","1/50","31/2914",0.416865170840721,0.486501686793518,0.338392298141209,"STAT3",1
"R-HSA-447115","R-HSA-447115","Interleukin-12 family signaling","1/50","32/2914",0.426978504679765,0.496034253728201,0.345022793614868,"STAT3",1
"R-HSA-6782135","R-HSA-6782135","Dual incision in TC-NER","1/50","32/2914",0.426978504679765,0.496034253728201,0.345022793614868,"EP300",1
"R-HSA-4420097","R-HSA-4420097","VEGFA-VEGFR2 Pathway","2/50","85/2914",0.431760864298819,0.500450092709995,0.348094285331823,"MAPK11/CTNNA1",2
"R-HSA-5685942","R-HSA-5685942","HDR through Homologous Recombination (HRR)","1/50","33/2914",0.436919890788721,0.50186744212218,0.349080140340917,"CHEK1",1
"R-HSA-6782210","R-HSA-6782210","Gap-filling DNA repair synthesis and ligation in TC-NER","1/50","33/2914",0.436919890788721,0.50186744212218,0.349080140340917,"EP300",1
"R-HSA-69052","R-HSA-69052","Switching of origins to a post-replicative state","1/50","33/2914",0.436919890788721,0.50186744212218,0.349080140340917,"CDK2",1
"R-HSA-76009","R-HSA-76009","Platelet Aggregation (Plug Formation)","1/50","33/2914",0.436919890788721,0.50186744212218,0.349080140340917,"SYK",1
"R-HSA-112040","R-HSA-112040","G-protein mediated events","1/50","34/2914",0.446692193968368,0.504011103813867,0.350571190888077,"MAPK1",1
"R-HSA-112043","R-HSA-112043","PLC beta mediated events","1/50","34/2914",0.446692193968368,0.504011103813867,0.350571190888077,"MAPK1",1
"R-HSA-1169408","R-HSA-1169408","ISG15 antiviral mechanism","1/50","34/2914",0.446692193968368,0.504011103813867,0.350571190888077,"MAPK3",1
"R-HSA-1834949","R-HSA-1834949","Cytosolic sensors of pathogen-associated DNA ","1/50","34/2914",0.446692193968368,0.504011103813867,0.350571190888077,"EP300",1
"R-HSA-2500257","R-HSA-2500257","Resolution of Sister Chromatid Cohesion","1/50","34/2914",0.446692193968368,0.504011103813867,0.350571190888077,"CDK1",1
"R-HSA-3214847","R-HSA-3214847","HATs acetylate histones","1/50","34/2914",0.446692193968368,0.504011103813867,0.350571190888077,"EP300",1
"R-HSA-446203","R-HSA-446203","Asparagine N-linked glycosylation","1/50","34/2914",0.446692193968368,0.504011103813867,0.350571190888077,"CSNK1D",1
"R-HSA-5687128","R-HSA-5687128","MAPK6/MAPK4 signaling","1/50","34/2914",0.446692193968368,0.504011103813867,0.350571190888077,"CDK1",1
"R-HSA-112315","R-HSA-112315","Transmission across Chemical Synapses","2/50","88/2914",0.449514118013138,0.506075497100884,0.352007105310625,"MAPK1/MAPK3",2
"R-HSA-199991","R-HSA-199991","Membrane Trafficking","3/50","144/2914",0.45271566381647,0.508105018463842,0.353418764132745,"CSNK1D/YWHAZ/SFN",3
"R-HSA-1169410","R-HSA-1169410","Antiviral mechanism by IFN-stimulated genes","1/50","35/2914",0.456298232267529,0.508105018463842,0.353418764132745,"MAPK3",1
"R-HSA-373752","R-HSA-373752","Netrin-1 signaling","1/50","35/2914",0.456298232267529,0.508105018463842,0.353418764132745,"MAPK11",1
"R-HSA-446728","R-HSA-446728","Cell junction organization","1/50","35/2914",0.456298232267529,0.508105018463842,0.353418764132745,"CTNNA1",1
"R-HSA-5610787","R-HSA-5610787","Hedgehog 'off' state","1/50","35/2914",0.456298232267529,0.508105018463842,0.353418764132745,"GSK3B",1
"R-HSA-194138","R-HSA-194138","Signaling by VEGF","2/50","92/2914",0.472714196647544,0.525237996275049,0.365335819906484,"MAPK11/CTNNA1",2
"R-HSA-3899300","R-HSA-3899300","SUMOylation of transcription cofactors","1/50","37/2914",0.475022557130162,0.525513024157012,0.365527118969893,"EP300",1
"R-HSA-9012852","R-HSA-9012852","Signaling by NOTCH3","1/50","37/2914",0.475022557130162,0.525513024157012,0.365527118969893,"EP300",1
"R-HSA-1592230","R-HSA-1592230","Mitochondrial biogenesis","1/50","38/2914",0.4841462526962,0.530999115860348,0.369343038276445,"MAPK11",1
"R-HSA-2871837","R-HSA-2871837","FCERI mediated NF-kB activation","1/50","38/2914",0.4841462526962,0.530999115860348,0.369343038276445,"FBXW11",1
"R-HSA-3108214","R-HSA-3108214","SUMOylation of DNA damage response and repair proteins","1/50","38/2914",0.4841462526962,0.530999115860348,0.369343038276445,"PML",1
"R-HSA-373755","R-HSA-373755","Semaphorin interactions","1/50","38/2914",0.4841462526962,0.530999115860348,0.369343038276445,"GSK3B",1
"R-HSA-1168372","R-HSA-1168372","Downstream signaling events of B Cell Receptor (BCR)","1/50","39/2914",0.493114502823178,0.537368368461156,0.37377325112778,"FBXW11",1
"R-HSA-6781827","R-HSA-6781827","Transcription-Coupled Nucleotide Excision Repair (TC-NER)","1/50","39/2914",0.493114502823178,0.537368368461156,0.37377325112778,"EP300",1
"R-HSA-69202","R-HSA-69202","Cyclin E associated events during G1/S transition ","1/50","39/2914",0.493114502823178,0.537368368461156,0.37377325112778,"CDK2",1
"R-HSA-381340","R-HSA-381340","Transcriptional regulation of white adipocyte differentiation","1/50","40/2914",0.50192990277408,0.542339513590637,0.377230992941269,"EP300",1
"R-HSA-69231","R-HSA-69231","Cyclin D associated events in G1","1/50","40/2914",0.50192990277408,0.542339513590637,0.377230992941269,"ABL1",1
"R-HSA-69236","R-HSA-69236","G1 Phase","1/50","40/2914",0.50192990277408,0.542339513590637,0.377230992941269,"ABL1",1
"R-HSA-69656","R-HSA-69656","Cyclin A:Cdk2-associated events at S phase entry","1/50","40/2914",0.50192990277408,0.542339513590637,0.377230992941269,"CDK2",1
"R-HSA-8986944","R-HSA-8986944","Transcriptional Regulation by MECP2","1/50","41/2914",0.510595005370216,0.550535840885434,0.382932050316597,"HDAC1",1
"R-HSA-109704","R-HSA-109704","PI3K Cascade","1/50","42/2914",0.519112321670769,0.556191773218681,0.386866104385337,"FGF19",1
"R-HSA-6783783","R-HSA-6783783","Interleukin-10 signaling","1/50","42/2914",0.519112321670769,0.556191773218681,0.386866104385337,"STAT3",1
"R-HSA-909733","R-HSA-909733","Interferon alpha/beta signaling","1/50","42/2914",0.519112321670769,0.556191773218681,0.386866104385337,"SOCS3",1
"R-HSA-5653656","R-HSA-5653656","Vesicle-mediated transport","3/50","160/2914",0.524012061500085,0.560264468270531,0.389698918074652,"CSNK1D/YWHAZ/SFN",3
"R-HSA-1236394","R-HSA-1236394","Signaling by ERBB4","1/50","44/2914",0.535713434814066,0.570383824123536,0.396737561877465,"YAP1",1
"R-HSA-69239","R-HSA-69239","Synthesis of DNA","1/50","44/2914",0.535713434814066,0.570383824123536,0.396737561877465,"CDK2",1
"R-HSA-1226099","R-HSA-1226099","Signaling by FGFR in disease","1/50","45/2914",0.543802050932288,0.575641705679238,0.400394746777922,"STAT3",1
"R-HSA-5668541","R-HSA-5668541","TNFR2 non-canonical NF-kB pathway","1/50","45/2914",0.543802050932288,0.575641705679238,0.400394746777922,"FBXW11",1
"R-HSA-112316","R-HSA-112316","Neuronal System","2/50","105/2914",0.544037847328221,0.575641705679238,0.400394746777922,"MAPK1/MAPK3",2
"R-HSA-112399","R-HSA-112399","IRS-mediated signalling","1/50","46/2914",0.551752520591886,0.582595829196401,0.405231773868291,"FGF19",1
"R-HSA-162909","R-HSA-162909","Host Interactions of HIV factors","1/50","49/2914",0.574797982659184,0.604426744651925,0.420416538591741,"LCK",1
"R-HSA-186797","R-HSA-186797","Signaling by PDGF","1/50","49/2914",0.574797982659184,0.604426744651925,0.420416538591741,"STAT3",1
"R-HSA-2428928","R-HSA-2428928","IRS-related events triggered by IGF1R","1/50","50/2914",0.582218611234067,0.609715588766682,0.424095259885185,"FGF19",1
"R-HSA-8957275","R-HSA-8957275","Post-translational protein phosphorylation","1/50","50/2914",0.582218611234067,0.609715588766682,0.424095259885185,"MEN1",1
"R-HSA-2404192","R-HSA-2404192","Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)","1/50","51/2914",0.589512280730679,0.613574006474788,0.426779030303413,"FGF19",1
"R-HSA-2428924","R-HSA-2428924","IGF1R signaling cascade","1/50","51/2914",0.589512280730679,0.613574006474788,0.426779030303413,"FGF19",1
"R-HSA-69306","R-HSA-69306","DNA Replication","1/50","51/2914",0.589512280730679,0.613574006474788,0.426779030303413,"CDK2",1
"R-HSA-388841","R-HSA-388841","Costimulation by the CD28 family","1/50","53/2914",0.60372722172984,0.627089374912868,0.436179812890891,"LCK",1
"R-HSA-5358351","R-HSA-5358351","Signaling by Hedgehog","1/50","55/2914",0.617459417949376,0.638751122016596,0.444291286108551,"GSK3B",1
"R-HSA-5696398","R-HSA-5696398","Nucleotide Excision Repair","1/50","55/2914",0.617459417949376,0.638751122016596,0.444291286108551,"EP300",1
"R-HSA-1500931","R-HSA-1500931","Cell-Cell communication","1/50","57/2914",0.630724940172183,0.649837817147097,0.452002774775174,"CTNNA1",1
"R-HSA-9020702","R-HSA-9020702","Interleukin-1 signaling","1/50","57/2914",0.630724940172183,0.649837817147097,0.452002774775174,"FBXW11",1
"R-HSA-111885","R-HSA-111885","Opioid Signalling","1/50","59/2914",0.643539334959354,0.661703751671917,0.460256273092747,"MAPK1",1
"R-HSA-381426","R-HSA-381426","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)","1/50","61/2914",0.655917641397886,0.67307444087107,0.468165297365429,"MEN1",1
"R-HSA-6806834","R-HSA-6806834","Signaling by MET","1/50","62/2914",0.661947826441736,0.677898376476477,0.471520645763824,"STAT3",1
"R-HSA-376176","R-HSA-376176","Signaling by ROBO receptors","1/50","64/2914",0.673699128346612,0.688550211336217,0.478929661961414,"ABL1",1
"R-HSA-168928","R-HSA-168928","DDX58/IFIH1-mediated induction of interferon-alpha/beta","1/50","66/2914",0.685049824644913,0.698750821137812,0.486024822958602,"EP300",1
"R-HSA-202733","R-HSA-202733","Cell surface interactions at the vascular wall","1/50","69/2914",0.70135389825837,0.713953070083371,0.49659893626026,"LCK",1
"R-HSA-193704","R-HSA-193704","p75 NTR receptor-mediated signalling","1/50","76/2914",0.73624773034003,0.747980761899233,0.520267320454162,"HDAC1",1
"R-HSA-1430728","R-HSA-1430728","Metabolism","4/50","289/2914",0.746063048807608,0.756445635967953,0.526155168877606,"CSNK2A1/VDR/EP300/RXRB",4
"R-HSA-162906","R-HSA-162906","HIV Infection","1/50","80/2914",0.754358783990879,0.763339245705056,0.530950104855736,"LCK",1
"R-HSA-416476","R-HSA-416476","G alpha (q) signalling events","2/50","165/2914",0.785601259002806,0.793379489289963,0.551844969846682,"MAPK1/MAPK3",2
"R-HSA-73887","R-HSA-73887","Death Receptor Signalling","1/50","106/2914",0.845686002204828,0.852371267044392,0.592877434456058,"HDAC1",1
"R-HSA-5663205","R-HSA-5663205","Infectious disease","1/50","126/2914",0.892399758308973,0.89768023025163,0.624392647254488,"LCK",1
"R-HSA-418594","R-HSA-418594","G alpha (i) signalling events","1/50","217/2914",0.979830042264064,0.983687640855655,0.684216171245316,"MAPK1",1
"R-HSA-388396","R-HSA-388396","GPCR downstream signalling","2/50","436/2914",0.997201203354511,0.998876104607515,0.694780696084072,"MAPK1/MAPK3",2
"R-HSA-372790","R-HSA-372790","Signaling by GPCR","2/50","486/2914",0.998876104607515,0.998876104607515,0.694780696084072,"MAPK1/MAPK3",2
